[go: up one dir, main page]

WO2021026733A1 - Inhalation administration device and combined inhalation administration structure - Google Patents

Inhalation administration device and combined inhalation administration structure Download PDF

Info

Publication number
WO2021026733A1
WO2021026733A1 PCT/CN2019/100241 CN2019100241W WO2021026733A1 WO 2021026733 A1 WO2021026733 A1 WO 2021026733A1 CN 2019100241 W CN2019100241 W CN 2019100241W WO 2021026733 A1 WO2021026733 A1 WO 2021026733A1
Authority
WO
WIPO (PCT)
Prior art keywords
powder
swirling
drug delivery
delivery device
inhalation drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2019/100241
Other languages
French (fr)
Chinese (zh)
Inventor
张江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/CN2019/100241 priority Critical patent/WO2021026733A1/en
Publication of WO2021026733A1 publication Critical patent/WO2021026733A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators

Definitions

  • the present disclosure relates to the technical field of medical appliances, in particular to an inhalation drug delivery device and a combined structure of inhalation drug delivery.
  • COPD chronic obstructive pulmonary disease
  • Pulmonary inhalation is the first choice therapy for COPD and most lung diseases similar to COPD. It has the characteristics of targeting, high efficiency, quick effect, and small side effects.
  • Common formulations for inhalation administration include solution atomization, metered atomization and dry powder mist. Compared with solution atomization and metered atomization, dry powder aerosol has good compliance with inhalation administration, and is especially suitable for patients with chronic obstructive pulmonary disease.
  • the inhalation drug delivery device of the inhalation drug combination structure in the prior art has a poor suction effect on the powder.
  • the purpose of the present disclosure is to provide an inhalation drug delivery device and a combined structure for inhalation drug delivery to optimize the suction effect of the powder.
  • the first aspect of the present disclosure provides an inhalation drug delivery device.
  • the inhalation drug delivery device includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and a medicine powder accommodating cavity for sucking the medicine box.
  • the air-powder suction port of the medicinal powder, and the inhalation drug delivery device further includes a first swirling structure which is arranged between the vent and the medicinal powder accommodating cavity and is used to cause the airflow to generate a swirl before the medicinal powder is blown.
  • the inhalation drug delivery device further includes a flow-sharing structure disposed between the vent and the first swirling structure.
  • the first swirl structure includes an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end.
  • the swirl channel includes a swirling channel that surrounds from the center of the flow channel to the edge of the flow channel. Two or more swirling parts are arranged, and each swirling part is used to produce a swirling flow of part of the air flow input into it and output it.
  • the first swirl flow structure further includes an outer flow guide surface arranged on the outside of the first swirl part counted from the edge of the flow channel, and the outer flow guide surface is at least on the side of the air outlet end from the swirl flow channel.
  • the expansion area gradually increases from upstream to downstream.
  • the expansion surface includes a tapered surface structure.
  • an isolation structure for isolating the air flows of the two swirling parts is provided between adjacent swirling parts.
  • the isolation structure includes a first intermediate flow guide surface for guiding the airflow of the swirling part close to the center of the two swirling parts for its isolation and/or two swirling parts for isolating it.
  • the second intermediate flow guiding surface of the swirling part near the edge of the flow part to guide the air flow.
  • the first intermediate guide surface at least on the side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirl flow channel; and/or, the second intermediate guide surface is at least The side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from the upstream to the downstream of the swirl flow channel.
  • the first swirling structure is arranged at the opening of the powder containing cavity for introducing airflow.
  • the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture.
  • the inhalation drug delivery device further includes an air powder acceleration channel provided between the first swirl structure and the second swirl structure; and/or the inhalation drug delivery device further includes a second swirl structure The rectifying structure between the wind powder suction port.
  • the second swirling structure includes a swirling channel and swirling vanes arranged in the swirling channel.
  • the second aspect of the present disclosure provides an inhalation drug delivery combination structure, including a medicine box and an inhalation drug delivery device for sucking the powder placed in the medicine box.
  • the medicine box has a powder accommodating cavity for placing the powder.
  • the device includes a vent for introducing outside air, a medicine box placement cavity for placing the medicine box, and an air powder suction port for sucking the medicine powder in the medicine powder accommodating cavity.
  • the inhalation drug delivery device also includes a vent and A first swirling flow structure between the powder accommodating cavities and used for causing the airflow to generate swirling flow before blowing the powder.
  • the medicine box has an air inlet for introducing external air, and the first swirl structure is disposed at the air inlet.
  • the first swirl structure includes an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end.
  • the swirl channel includes a swirling channel that surrounds the flow channel from the inner side to the outer side of the flow channel. Two or more swirling parts are arranged, and each swirling part is used to produce a swirling flow of part of the air flow input into it and output it.
  • the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture.
  • the second swirling structure includes a swirling channel and swirling vanes arranged in the swirling channel.
  • the inhalation drug delivery device includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and a medicine powder container for sucking the medicine box
  • the air powder suction port for the powder in the cavity and the inhalation drug delivery device further includes a first swirling structure arranged between the vent and the powder containing cavity and used for causing the airflow to generate a swirl before the powder is blown.
  • the first swirling structure of the inhalation drug delivery device of the present disclosure causes the airflow to generate a swirling flow before the powder is blown, and the powder is blown out of the powder containing cavity more effectively, thereby optimizing the suction effect of the powder.
  • FIG. 1 is a schematic diagram of a three-dimensional structure of an inhalation drug delivery combination structure of an embodiment of the disclosure
  • FIG. 2 is a schematic diagram of another perspective three-dimensional structure of the combined structure of inhalation drug delivery according to the embodiments of the disclosure.
  • Figure 3 is a schematic diagram of an exploded structure of the inhalation drug delivery combination structure shown in Figure 1;
  • Figure 4 is a schematic diagram of the structure of the box in Figure 3;
  • FIG. 5 is a schematic structural view of one angle of the first accommodating body and the second accommodating body in FIG. 3;
  • FIG. 6 is a schematic structural view of another angle of the first accommodating body and the second accommodating body in FIG. 3;
  • Fig. 7 is a schematic structural diagram of each first swirl structure in Fig. 3;
  • Fig. 8 is a schematic structural diagram of a first swirl structure in Fig. 3;
  • Figure 9 is a schematic diagram of the structure of the turntable in Figure 3.
  • FIG. 10 is a schematic structural diagram of another angle of the turntable shown in FIG. 9;
  • Figure 11 is a schematic diagram of the structure of the elastic element in Figure 3.
  • Figure 12 is a schematic view of the structure of the pawl plate in Figure 3;
  • Figure 13 is a schematic diagram of the structure of the mounting plate in Figure 3;
  • Figure 14 is a schematic diagram of the structure of the limit plate in Figure 3;
  • Figure 15 is a schematic diagram of the structure of the outer ring of the turntable in Figure 3;
  • Fig. 16 is a schematic diagram of the structure of the sign disc in Fig. 3;
  • FIG. 18 is a schematic diagram of the structure of the second housing in FIG. 3;
  • Figure 19 is a schematic diagram of the structure of the trachea in Figure 3.
  • Fig. 20 is a schematic structural view of one direction of the suction nozzle in Fig. 3;
  • Fig. 21 is a schematic structural view of the suction nozzle in Fig. 3 in another direction.
  • spatially relative terms such as “above”, “above”, “above”, “above”, etc. can be used here to describe as shown in the figure. Shows the spatial positional relationship between one device or feature and other devices or features. It should be understood that the spatially relative terms are intended to encompass different orientations in use or operation other than the orientation of the device described in the figure. For example, if the device in the figure is inverted, then the device described as “above the other device or structure” or “above the other device or structure” will then be positioned as “below the other device or structure” or “on Under other devices or structures”. Thus, the exemplary term “above” can include both orientations “above” and “below”. The device can also be positioned in other different ways (rotated by 90 degrees or in other orientations), and the relative description of the space used here is explained accordingly.
  • the inhalation drug delivery device of the embodiment of the present disclosure includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and an air powder suction port for sucking medicine powder in the medicine powder accommodating cavity of the medicine box.
  • the inhalation drug delivery device also includes a first swirling structure arranged between the vent and the powder accommodating cavity and used for causing the airflow to generate swirl before the powder is blown.
  • the inhalation drug delivery device of the embodiment of the present disclosure generates a swirling flow on the airflow before impacting the powder by setting the first swirl structure to blow the powder out more effectively, thereby improving the suction effect of the powder.
  • the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture.
  • the second swirling structure generates a swirling flow on the air-powder mixture so that the powder is fully atomized to increase the absorption rate of the powder.
  • the combined structure for inhalation administration of this embodiment includes a medicine box and an inhalation administration device.
  • the inhalation drug delivery device is used to suck the powder in the medicine box.
  • the structure of the medicine box of this embodiment will be described in detail below.
  • the medicine box of this embodiment includes a box body 3 and a medicine powder containing body.
  • the powder containing body is arranged in the box body 3 and is provided with a powder containing cavity for placing the powder.
  • the powder accommodating cavity includes a first opening of the powder accommodating cavity for introducing airflow and a second opening of the powder accommodating cavity for outputting a mixture of air and powder.
  • the box body 3 is provided with an air inlet 3A for introducing outside air into the box body 3 and an air powder outlet 3B for outputting an air powder mixture.
  • the medicinal powder accommodating body is movably disposed relative to the box body 3 so that the medicinal powder accommodating cavity is switched between a closed state and an open state.
  • the box body 3 seals the first opening of the powder containing cavity and the second opening of the powder containing cavity.
  • the first opening of the powder accommodating cavity is in communication with the air inlet 3A
  • the second opening of the powder accommodating cavity is in communication with the air powder outlet 3B, so that the powder can interact with the inlet of the air inlet under the suction force of the air powder outlet. The outside air is sucked out from the fan outlet together.
  • the medicinal powder accommodating body is rotatably disposed relative to the box body 3 so that the medicinal powder accommodating cavity can be switched between a closed state and an open state.
  • the medicinal powder containing body is rotatably arranged relative to the box body so that the volume of the medicine box is small, which is convenient for storage and carrying.
  • the powder accommodating cavity may be arranged in a radial direction, or may be arranged in an axial direction, or may be arranged at an angle to the radial direction or an angle to the axial direction, for example.
  • the medicinal powder containing body is coaxially and rotatably arranged relative to the box body 3.
  • the box body 3 includes an annular box body.
  • the ring-shaped box body includes a first box body ring wall, a second box body ring wall, and an installation space formed between the first box body ring wall and the second box body ring wall.
  • the air inlet 3A is arranged on the annular wall of the first box body, and the air powder outlet 3B is arranged on the annular wall of the second box body.
  • the powder containing body is arranged in the installation space.
  • the medicinal powder container has a first container ring wall and a second container ring wall.
  • the powder accommodating cavity is located between the ring wall of the first accommodating body and the ring wall of the second accommodating body, the first opening of the powder accommodating cavity is provided on the ring wall of the first accommodating body, and the second opening of the powder accommodating cavity is provided on the ring wall of the second accommodating body on.
  • the first box body ring wall is the box body ring wall 31 located at the radial inner side of the ring box body.
  • the second box body ring wall is the box body ring wall 32 located on the radially outer side of the ring box body.
  • the first box body ring wall may be located radially outside of the ring box body, and the second box body ring wall may be located radially inside the ring box body.
  • the air inlet 3A and the air powder outlet 3B are arranged in the same direction in the radial direction of the box body 3.
  • the powder containing cavity extends along the radial direction of the powder containing body.
  • the powder containing body is controlled to rotate relative to the box body 3 to make the powder containing cavity communicate with the air inlet and the air powder outlet.
  • the powder containing body is controlled to rotate relative to the box body 3 so that the powder containing cavity rotates to a position closed by the box body 3.
  • the annular box body further includes a first end wall 33 arranged on the annular wall 31 of the box body.
  • the powder containing body is rotatably connected to the first end wall 33 and the first end
  • the wall 33 and the inner wall 31 of the box form an air inlet cavity communicating with the air inlet 3A.
  • the arrangement of the air inlet cavity allows a space between the external space of the inhalation and drug delivery combination structure and the air inlet 3A, which facilitates the installation of accessories such as a filter structure and a flow sharing structure.
  • the ring-shaped box body includes a second end wall 34 disposed between the inner ring wall 31 and the outer ring wall 32 of the box body.
  • the ring wall 31 inside the box, the ring wall 32 outside the box and the second end wall 34 enclose an annular groove, and the annular groove forms an installation space.
  • the second end wall 34 and the first end wall 33 are arranged at both axial ends of the box body 3.
  • the medicinal powder containing body may also be arranged translationally relative to the box body.
  • the medicinal powder containment body and the box body are both square structures, and the medicinal powder containment body is arranged in the box body and can be arranged translationally along the length direction of the box body.
  • the powder containing body includes a first containing part 4 and a second containing part 6.
  • the first accommodating sub-body 4 is provided with a first accommodating sub-cavity
  • the second accommodating sub-body 6 is provided with a second accommodating sub-cavity.
  • the first accommodating part 4 and the second accommodating part 6 are buckled so that the first accommodating cavities and the second accommodating cavities at corresponding positions jointly form a powder accommodating cavity.
  • the powder accommodating body of this embodiment is divided into two accommodating detached bodies that are interlocked with each other to facilitate the dispensing of the powder in the powder accommodating cavity.
  • the powder accommodating cavity in this embodiment is a cylindrical cavity structure.
  • the powder accommodating cavity can also be configured in other shapes, such as a square structure.
  • a connecting post is provided on one of the first accommodating body 4 and the second accommodating body 6 , The other is provided with a connecting hole, and the connecting post is penetrated through the connecting hole so that the first accommodating body 4 and the second accommodating body 6 are tightly buckled with each other.
  • the first accommodating body 4 is provided with both a connecting column and a connecting hole.
  • the second accommodating body 6 is provided with both a connecting column and a connecting hole.
  • the connecting post matched with the connecting hole provided on the receiving split body 4 is also provided with a connecting hole matched with the connecting post provided on the first receiving split body 4. This arrangement makes the assembly between the first accommodating body 4 and the second accommodating body 6 closer.
  • the connecting column in this embodiment has a circular structure, and the connecting hole has a square structure. This arrangement facilitates the combination of the powder container.
  • the first accommodating sub-body 4 of this embodiment has a ring structure and is sleeved on the outside of the ring wall 31 of the box body 3.
  • the second accommodating part 6 is buckled with the first accommodating part 4 and arranged on the first end wall 33.
  • the first end wall 33 is provided with a through hole 33A.
  • the second accommodating body 6 is provided with a rotating shaft 6A, and the rotating shaft 6A penetrates through the through hole 33A to make the second accommodating body 6 rotatable relative to the box body 3, because the first accommodating body 4 and the second accommodating body
  • the split bodies 6 are connected to each other, so that the rotation of the second accommodating split body 6 relative to the box body 3 can drive the first accommodating split body 4 to rotate synchronously.
  • the powder containing body of this embodiment includes more than two powder containing cavities.
  • the two or more powder-containing cavities of the medicine box of this embodiment can contain multiple doses of powder.
  • the patient uses the medicine box of this embodiment for inhalation, he can control the powder-containing body to rotate relative to the box body 3 so that the two More than one medicated powder accommodating cavities are sequentially in an open state, and the medicinal powders in different medicated powder accommodating cavities are sequentially sucked.
  • two or more medicated powder containing cavities can be placed in different types of medicated powder, or the same type of medicated powder can be placed.
  • the medicine box of this embodiment is convenient for patients to take medicine.
  • Figures 5 and 6 schematically show that the powder containing body of the medicine box has seven powder containing cavities.
  • the powder containing body is rotatably arranged relative to the box body 3 so that the seven powder containing cavities are connected to the air inlet 3A and the air powder outlet in sequence. 3B is connected.
  • the inhalation drug delivery device of this embodiment includes a housing and a suction nozzle 16 for installing a medicine box.
  • the casing is provided with the aforementioned vent for introducing external air and a medicine box placing cavity for placing the medicine box.
  • the suction nozzle 16 has an air powder suction port for sucking the powder in the medicine box.
  • the suction nozzle 16 of this embodiment has an air powder suction channel and an air powder suction port 16A disposed at an end of the air powder suction channel away from the medicine box.
  • the housing of this embodiment includes a first housing 1 and a second housing 2.
  • the first housing 1 is provided with a vent 1A for introducing outside air.
  • the second housing 2 has a medicine box placement cavity.
  • the medicine box placement cavity has a first medicine box placement cavity opening 2A communicating with the vent 1A.
  • the first medicine box placement cavity opening 2A communicates with the air inlet 3A of the box body of the medicine box to introduce outside air into the box body 3.
  • the medicine box placement cavity of this embodiment also has a second medicine box placement cavity opening communicating with the air powder suction port. The patient sucks the powder from the wind powder outlet through the wind powder suction channel of the suction nozzle 16.
  • the vent 1A of the first housing 1 of this embodiment is provided with a filtering structure.
  • the opening 2A of the first medicine box placement cavity of the second casing of this embodiment is provided with a flow-sharing structure.
  • the suction nozzle 16 of this embodiment includes a nozzle body 161 and an oral cavity 162 for mounting the suction nozzle 16 on the housing.
  • the oral cavity 162 is provided with the above-mentioned air-powder suction port 16A to provide suction force for sucking the powder.
  • the oral cavity 162 can be sucked into the body by putting the oral cavity 162 into the mouth and inhaling hard.
  • the inhalation drug delivery device of this embodiment further includes a suction nozzle cover 18 provided outside the suction nozzle 16.
  • the inhalation drug delivery device of this embodiment further includes a first swirler arranged between the vent 1A and the medicinal powder accommodating cavity and used to cause the airflow to generate a swirl before the powder is blown.
  • Flow structure 5 in order to fully atomize the medicinal powder, the inhalation drug delivery device of this embodiment further includes a first swirler arranged between the vent 1A and the medicinal powder accommodating cavity and used to cause the airflow to generate a swirl before the powder is blown.
  • the first swirling structure includes an airflow inlet end, an airflow outlet end, and a swirling channel disposed between the airflow inlet end and the airflow outlet end, and the swirling channel includes a flow path from the center of the flow channel.
  • Two or more swirling parts are arranged around the edge of the flow channel in turn, and each swirling part is used to generate a swirling flow of part of the airflow input into it and output it.
  • the first swirling structure causes the airflow to generate a swirling flow before blowing the powder to make the powder fully atomized, thereby increasing the proportion of the powder being inhaled into the lungs.
  • the first swirling structure 5 of this embodiment is arranged upstream of the first opening of the powder containing cavity.
  • the first swirl structure 5 of this embodiment is a circular structure.
  • a first swirling structure 5 is arranged upstream of the first opening of the powder accommodating cavity so that the airflow generates swirl before blowing the powder to increase the suction volume of the powder, thereby increasing the proportion of the powder being inhaled into the lungs.
  • the medicine box of this embodiment includes two or more first swirling structures 5 corresponding to two or more powder containing cavities. To facilitate assembly, two or more first swirl structures 5 can be connected together.
  • the first swirl structure 5 of this embodiment has an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end.
  • the swirling channel includes two or more swirling parts arranged sequentially from the radially inner side of the flow channel to the radially outer side of the flow channel, and each swirling part is used to generate a swirling flow of a part of the airflow input into it and output it.
  • two or more swirling parts are arranged in the swirl channel, so that the difference between the radial inner side of the flow channel and the radial outer side of the flow channel of the swirl channel is different.
  • the airflow at different positions can produce swirling flow, so the airflows at different positions in the entire flow channel can produce swirling flow, which increases the suction volume of powder.
  • the first swirling structure 5 of this embodiment includes a first swirling portion 51 and a second swirling portion 52.
  • the directions of the swirling flows generated by the first swirling part 51 and the second swirling part 52 are opposite.
  • the medicine box of this embodiment sets the direction of the swirling flow generated by the adjacent swirling parts to be reversed, so that the airflow before blowing the medicine powder forms a swirling flow of different directions, so that the direction of the impact force on the medicine powder is also different. It can better atomize the medicine powder into a smaller powder, which is easier to be absorbed by the patient.
  • the first swirl structure 5 is arranged at the air inlet 3A.
  • the end surface of the air inlet end of the first swirl structure 5 is in contact with the end surface of the air inlet of the medicine box and is shape-matched.
  • the first swirling structure 5 of this embodiment is arranged at the air inlet 3A of the box body 3.
  • the end surface of the airflow inlet end of the first swirling structure 5 is in contact with the box body 3, and the airflow outlet end of the first swirling structure 5 is The end surface is in contact with the powder containing body.
  • the first swirling structure may also be arranged at other positions on the airflow channel between the vent and the powder containing cavity.
  • the first swirl structure may also be arranged at the opening of the first medicine box placement cavity.
  • the first box body ring wall of the box body 3 has a cylindrical structure. Therefore, as shown in FIG. 8, the end surface of the air inlet end of the first swirl structure 5 is set to protrude toward the air outlet end side. Cylindrical arc structure.
  • the first swirl structure 5 further includes an outer flow guide surface arranged on the outside of the first swirl part counted from the outside of the flow channel.
  • the outer guide surface is an expansion surface that gradually increases from the upstream to the downstream of the swirling channel at least on the side of the air outlet end. The setting of the outer diversion surface as an expanded surface facilitates the airflow to impact the powder located at the cavity wall of the powder containing cavity, thereby reducing the residual powder and increasing the amount of powder entering the patient's oral cavity.
  • the expansion surface includes a tapered surface structure.
  • the adjacent swirling parts of this embodiment are provided between the two adjacent swirling parts. Airflow isolation structure 53.
  • the isolation structure 53 includes a first intermediate flow guide surface for guiding the airflow of the inner swirling part of the two swirling parts for isolation, and two swirling parts for isolating it.
  • the second middle guide surface for guiding the airflow of the middle and outer swirling parts.
  • the first intermediate guide surface at least on the side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirl flow channel
  • the second intermediate guide surface is at least on the side of the air outlet end.
  • the cross-sectional area gradually increases from the upstream to the downstream of the swirl flow channel.
  • the arrangement of the expansion surface can also make the air flow impact the powder located on the wall of the powder containing cavity, thereby increasing the amount of powder entering the patient's oral cavity.
  • the inhalation drug delivery device of this embodiment is provided with a first swirl structure to cause the airflow to swirl before blowing the powder to make the powder fully atomized, thereby increasing the proportion of the powder being inhaled into the lungs.
  • the inhalation drug delivery device of this embodiment also includes a device that is arranged between the powder accommodating cavity and the air powder suction port and is used to generate the air powder mixture.
  • the swirling second swirling structure 19 The inhalation drug delivery device of this embodiment is provided with a first swirling structure 5 that generates a swirling flow on the airflow before impacting the powder and a second swirling structure 19 that swirls the wind and powder mixture to fully atomize the powder to improve the powder.
  • the absorption rate is provided with a first swirling structure 5 that generates a swirling flow on the airflow before impacting the powder.
  • the second swirl structure 19 is arranged on the air powder suction channel.
  • the second swirling structure 19 causes the air-powder mixture at the air-powder outlet to generate a swirling flow when passing through the air-powder suction channel and further atomize, thereby improving the atomization effect of the medicinal powder and further improving the patient's absorption rate of the medicinal powder.
  • the second swirling structure 19 includes a swirling passage and swirling vanes arranged in the swirling passage.
  • the air and powder suction channel forms a swirling channel of the second swirling structure.
  • the swirling blade is fixedly arranged relative to the swirling passage. This setting helps to maintain the stability of the amount of powder inhaled each time.
  • the first swirling structure may also include swirling channels and swirling vanes arranged in the swirling channels.
  • the second swirling flow structure may also include an airflow inlet end, an airflow outlet end, and a swirling channel arranged between the airflow inlet end and the airflow outlet end, and the swirling channel includes a flow path from the center to Two or more swirling parts are arranged around the edge of the flow channel in turn, and each swirling part is used to generate a swirling flow of part of the airflow input into it and output it.
  • the suction nozzle 16 of this embodiment further includes an air pipe 15 provided between the nozzle body 161 and the housing.
  • the trachea 15 is connected to the housing through a trachea connecting portion 17.
  • the inner cavity of the trachea 15 forms part of the air powder suction channel.
  • the air pipe 15 is provided with a rectifying structure 151 for rectifying the air and powder mixture.
  • the second swirling structure 19 is arranged downstream of the rectifying structure 151, that is, the rectifying structure 151 is arranged between the first swirling structure 5 and the second swirling structure 19. Therefore, the airflow generates a swirling flow before blowing the powder, and then mixes with the powder to form a wind powder mixture. After the air and powder mixture is formed, the air and powder mixture is rectified through the rectifying structure 151 to make the air and powder mixture flow smoothly in the entire air and powder suction channel, and then the air and powder mixture in the entire air and powder suction channel is processed through the second swirl structure 19 The swirling flow can make more air and powder mixture swirl, so that the powder can be fully atomized.
  • the inhalation drug delivery device of this embodiment further includes a wind powder acceleration channel arranged between the first swirling structure 5 and the second swirling structure 19.
  • the air-powder acceleration channel enables the medicinal powder to be fully accelerated under the driving of the airflow, so that the medicinal powder enters the second swirling structure at a relatively fast speed to effectively disperse the medicinal powder for full atomization.
  • the wind and powder acceleration channel is an acceleration cavity provided between the first swirl structure 5 and the second swirl structure 19.
  • the acceleration cavity provides a space for the acceleration of the powder, so that the powder can have a faster speed when it enters the second swirl structure.
  • the length of the acceleration cavity is greater than or equal to 10 mm.
  • the length of the acceleration cavity is greater than 20 mm.
  • the oral cavity 162 of this embodiment further has a peripheral wind suction port 16B that is provided on the side of the air powder suction port 16A and communicates with the atmosphere to form peripheral wind outside the air powder suction port 16A.
  • the peripheral air suction port 16B is arranged so that peripheral air is formed outside the air powder suction port 16A. Therefore, when the powder passes through the oral cavity, the peripheral air outside the main channel of the powder circulation forms a certain isolation effect on the powder, so that the powder It is more difficult to adhere to the oral cavity wall, so the proportion of powder that enters the lungs is increased.
  • a gas containing space is formed between the first housing 1 and the second housing 2.
  • Part of the gas entering the first housing 1 through the vent 1A of the first housing 1 enters the medicine box through the opening of the first medicine box placement cavity on the second housing, and partly enters the first housing 1 and the second housing In the gas containing space formed between the bodies 2.
  • the suction nozzle 16 is arranged on the housing.
  • the air powder suction port 16A of the suction nozzle 16 communicates with the opening of the second medicine box placement cavity on the second housing through the air powder suction channel to suck the powder.
  • the peripheral wind suction port 16B of the suction nozzle 16 located on the side of the wind powder suction port communicates with the gas storage space to communicate with the atmosphere to form peripheral wind.
  • the filter structure of the first housing 1 is provided with a support portion 1B extending toward the inner side of the first housing 1.
  • the support portion 1B provides a gap between the second housing 2 and the first housing 1. Therefore, the outer surface of the medicine box placement cavity of the second housing 2 and A gas containing space is formed between the first housing 1.
  • the suction nozzle 16 is installed on the housing, the peripheral wind suction port of the suction nozzle 16 can suck the gas in the gas containing space to form the peripheral wind.
  • the oral cavity 162 is provided with at least two peripheral wind suction ports 16B located at different positions in the circumferential direction of the wind powder suction port 16A. This arrangement can increase the outlet point of the surrounding wind and better prevent the powder from sticking to the oral cavity wall.
  • the air powder suction port 16A of this embodiment is provided with two symmetrical sides on both sides. Peripheral wind suction ports 16B.
  • At least two peripheral air suction openings may also be arranged around the air powder suction opening. Such arrangement makes the peripheral wind formed in the circumferential direction of the wind powder suction channel, and prevents the powder from adhering to the oral cavity wall in all directions.
  • the oral cavity 162 includes a suction end surface located on one side of the oral cavity during suction.
  • the air powder suction opening 16A and the peripheral air suction opening 16B are both arranged on the suction end surface.
  • the suction end surface of this embodiment includes a curved surface protruding to the side away from the oral cavity.
  • the curved surface forms a recessed space to facilitate the oral cavity to effectively fit the lips to prevent the side of the oral cavity from showing, and to avoid the tongue as much as possible to prevent the powder from adhering to the oral cavity and the tongue.
  • the curved surface is an arc cylindrical surface.
  • the oral cavity of this embodiment includes two peripheral air suction openings located at both ends of the air powder suction opening, and The center of the wind suction port and the center of the wind powder suction port are both located on the same straight line parallel to the generatrix of the arc cylindrical surface.
  • the inhalation drug delivery device of this embodiment includes a driving mechanism for driving the powder container to move relative to the box body 3.
  • the driving mechanism includes a pawl plate 9 rotatable relative to the box body 3.
  • the pawl plate 9 is provided with a pawl plate pawl 91.
  • the medicine powder container is provided with container ratchets.
  • the pawl disc pawl 91 drives the ratchet tooth of the container to rotate to drive the powder container to rotate.
  • a container ratchet 61 is provided on the top surface of the second container body 6 of the powder container.
  • the pawl plate 9 equipped with the pawl plate pawl 91 is installed on the mounting plate 7 and cooperates with the container ratchet provided on the powder container to drive the second container body 6 to rotate.
  • the second accommodating body 6 is connected to the first accommodating body 4, so the first accommodating body 4 can also rotate synchronously with the second accommodating body 6 to realize the rotation of the powder accommodating body.
  • the mounting plate 7 is provided with a plurality of connecting bars 71 arranged at intervals in the circumferential direction.
  • a plurality of connecting protrusions 92 are provided on the pawl plate 9. The connecting bar 71 is clamped between the two connecting protrusions 92 to install the pawl plate on the mounting plate 7.
  • the combined structure for inhalation and drug delivery in this embodiment further includes a turntable 13 provided with a knob.
  • the pawl plate 9 is connected with the turntable 13 to rotate synchronously under the drive of the turntable 13.
  • the pawl of the turntable can be directly matched with the ratchet teeth of the container to drive the powder container to rotate.
  • the inhalation drug delivery device of this embodiment further includes an information display structure for displaying the use information of the medicine box.
  • the powder containing body includes more than two powder containing cavities.
  • the information display structure includes two or more flag plates 8 corresponding to two or more powder containing cavities.
  • the marking disc 8 rotates synchronously with the powder containing body.
  • the combined structure of inhalation drug delivery in this embodiment includes a marker disk 8 and a turntable outer ring 10.
  • the turntable outer ring 10 is fixedly arranged relative to the box body 3.
  • a window 10A is provided on the outer ring 10 of the turntable.
  • the marking plate 8 is provided on the lower side of the outer ring 10 of the turntable.
  • the window 10A can display the marks on the sign disc 8 while the sign disc 8 is rotating.
  • the turntable 13 is arranged in the middle of the outer ring 10 of the turntable, and an arrow is provided on the outer ring 10 to show the direction in which the turntable 13 rotates.
  • the index plate 8 is provided with counting marks corresponding to more than two powder containing cavities.
  • the marking plate 8 rotates synchronously with respect to the powder containing body to display the usage of the powder in the multiple powder containing cavities in the powder containing body.
  • the medicine box of this embodiment there are seven medicine powder containing chambers.
  • the count mark on the mark plate 8 is displayed as zero.
  • the counting mark of the marking plate 8 gradually becomes larger.
  • the patient can know that the powder in the medicine box has been used up, and can replace the medicine box with a new one.
  • the setting of the indicator disc 8 makes the combined structure of inhalation and administration of this embodiment more convenient to use.
  • the mark on the mark disc may also include the use information of the medicine box such as the powder type information.
  • the mark on the marking plate may be the powder type information corresponding to the type of medicated powder in the medicated powder containing chamber.
  • a sign disc ratchet is provided on the inner edge of the sign disc 8.
  • the turntable 13 is provided with a turntable pawl 131.
  • the pawl 131 of the turntable cooperates with the ratchet teeth of the sign disc to drive the ratchet teeth of the sign disc to rotate.
  • the turntable 13 drives the pawl disc 9 to rotate synchronously, so that the sign disc 8 and the powder containing body rotate synchronously, so that the counting marks on the sign disc 8 can be It shows the state of use of the powder containing cavity of the powder containing body.
  • the combined structure for inhalation administration further includes an elastic element 12 for automatically returning the pawl of the turntable.
  • the first end of the elastic element 12 and the turntable 13 are relatively fixedly arranged.
  • the second end of the box 3 is relatively fixedly arranged.
  • the bottom of the turntable 13 is provided with a first connecting groove 13A, and the first end of the elastic element 12 is connected in the first connecting groove 13A.
  • the combined structure of inhalation drug delivery in this embodiment further includes a limiting disk 11 fixedly arranged relative to the box body 3.
  • a second connecting groove 11B is provided on the limit disk 11.
  • the second end of the elastic element 12 is connected to the second connecting groove 11B. Since the first end of the elastic element 12 is fixedly connected to the turntable 13 and the second end of the elastic element 12 is fixedly connected to the limit disk 11, the turntable 13 can automatically return under the pulling of the elastic element 12 after rotating.
  • the elastic element 12 is a torsion spring.
  • the limit disk 11 of this embodiment is provided with a limit slot 11A.
  • a limiting protrusion 132 is provided on the turntable 13. The limiting protrusion 132 swings in the limiting slot 11A to limit the rotation range of the turntable pawl 131 each time.
  • the limit disk of this embodiment is provided with two limit grooves arranged symmetrically.
  • the two limiting grooves respectively cooperate with the two limiting protrusions on the turntable 13.
  • the driving mechanism of this embodiment is provided with a turntable 13 and a pawl plate 9 that rotates synchronously with the turntable 13 so that the turntable pawls on the turntable 13 drive the sign plate 8 to rotate while the turntable 13 drives the powder containing body to rotate, thereby realizing the sign plate 8 Display of the powder usage status of the powder container.
  • a knob is provided on the turntable 13 to facilitate the operation of the patient.
  • the first preparation and the second preparation were used to test the powder suction effect of the medicine box with the first swirl structure and the powder suction effect of the medicine box without the first swirl structure.
  • the test results are shown in the table 1 shown.
  • the powder particle diameter of the first preparation is 10 ⁇ m.
  • the diameter of the powder particles of the second preparation is 2.8 ⁇ m.
  • the powder suction volume of the medicine box with the first swirl structure is greater than that without the first swirl structure.
  • the powder suction volume of the medicine box with flow structure it can be seen that the provision of the first swirl structure can increase the amount of powder that is sucked out of the medicine box.
  • the mass average aerodynamic diameter of the powder sucked by the medicine box with the second swirl structure is smaller than that of the medicine box without the second swirl structure.
  • the mass average aerodynamic diameter of the powder is larger than that of the medicine box without the second swirl structure.
  • the proportion of the average aerodynamic diameter of the corresponding mass in the powder is larger.
  • the inhalation drug delivery device of the embodiments of the present disclosure has at least the following advantages:
  • the first swirling structure is arranged in the medicine box to increase the suction volume of the medicine powder.
  • the second swirl structure is provided to improve the atomization effect of the powder, thereby increasing the amount of powder inhaled by the patient.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed are an inhalation administration device and a combined inhalation administration structure. The inhalation administration device comprises a ventilation opening (1A) for introducing external air, a medicine box placement cavity for the placement of a medicine box, and an air powder suction opening (16A) for sucking a medicine powder into a medicine powder accommodation cavity of the medicine box, and the inhalation administration device further comprises a first rotational flow structure (5) arranged between the ventilation opening (1A) and the medicine powder accommodation cavity and used for generating a rotational flow before an air flow blows the medicine powder. The first rotational flow structure (5) of the inhalation administration device generates the rotational flow before the air flow blows the medicine powder, such that the air flow can more effectively blow the medicine powder out of the medicine powder accommodation cavity, thereby optimizing the suction effect of the medicine powder.

Description

吸入给药装置和吸入给药组合结构Inhalation drug delivery device and inhalation drug delivery combined structure 技术领域Technical field

本公开涉及医疗用具技术领域,特别涉及一种吸入给药装置和吸入给药组合结构。The present disclosure relates to the technical field of medical appliances, in particular to an inhalation drug delivery device and a combined structure of inhalation drug delivery.

背景技术Background technique

慢性阻塞性肺病(慢阻肺)是以不完全可逆的气流受限为特征的慢性肺部疾病。世界卫生组织估计慢阻肺在我国的疾病死因上居第三,仅次于肿瘤和脑血管病。Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by incompletely reversible airflow limitation. The World Health Organization estimates that COPD is the third cause of death in my country, second only to tumors and cerebrovascular diseases.

肺部吸入给药是慢阻肺及类似于慢阻肺的大多数肺部疾病的首选疗法,具有靶向、高效、速效、毒副作用小等特点。常见的吸入给药制剂包括溶液雾化、计量雾化和干粉粉雾。与溶液雾化和计量雾化相比,干粉粉雾剂吸入给药顺应性好,特别适用于慢阻肺病人。Pulmonary inhalation is the first choice therapy for COPD and most lung diseases similar to COPD. It has the characteristics of targeting, high efficiency, quick effect, and small side effects. Common formulations for inhalation administration include solution atomization, metered atomization and dry powder mist. Compared with solution atomization and metered atomization, dry powder aerosol has good compliance with inhalation administration, and is especially suitable for patients with chronic obstructive pulmonary disease.

现有技术中的吸入给药组合结构的吸入给药装置对药粉的抽吸效果不好。The inhalation drug delivery device of the inhalation drug combination structure in the prior art has a poor suction effect on the powder.

发明内容Summary of the invention

本公开的目的在于提供一种吸入给药装置和吸入给药组合结构,以优化药粉的抽吸效果。The purpose of the present disclosure is to provide an inhalation drug delivery device and a combined structure for inhalation drug delivery to optimize the suction effect of the powder.

本公开第一方面提供一种吸入给药装置,吸入给药装置包括用于引入外部空气的通气口、用于放置药盒的药盒放置腔和用于抽吸药盒的药粉容纳腔内的药粉的风粉抽吸口,吸入给药装置还包括设置于通气口与药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构。The first aspect of the present disclosure provides an inhalation drug delivery device. The inhalation drug delivery device includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and a medicine powder accommodating cavity for sucking the medicine box. The air-powder suction port of the medicinal powder, and the inhalation drug delivery device further includes a first swirling structure which is arranged between the vent and the medicinal powder accommodating cavity and is used to cause the airflow to generate a swirl before the medicinal powder is blown.

在一些实施例中,吸入给药装置还包括设置于通气口与第一旋流结构之间的均流结构。In some embodiments, the inhalation drug delivery device further includes a flow-sharing structure disposed between the vent and the first swirling structure.

在一些实施例中,第一旋流结构包括气流入口端、气流出口端和设置于气流入口端和气流出口端之间的旋流通道,旋流通道包括从流道中心至流道边缘依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。In some embodiments, the first swirl structure includes an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end. The swirl channel includes a swirling channel that surrounds from the center of the flow channel to the edge of the flow channel. Two or more swirling parts are arranged, and each swirling part is used to produce a swirling flow of part of the air flow input into it and output it.

在一些实施例中,第一旋流结构还包括设置于从流道边缘数第一个旋流部外侧的外侧导流面,外侧导流面至少在气流出口端一侧为从旋流通道的上游至下游逐渐变大 的扩张面。In some embodiments, the first swirl flow structure further includes an outer flow guide surface arranged on the outside of the first swirl part counted from the edge of the flow channel, and the outer flow guide surface is at least on the side of the air outlet end from the swirl flow channel. The expansion area gradually increases from upstream to downstream.

在一些实施例中,扩张面包括锥面结构。In some embodiments, the expansion surface includes a tapered surface structure.

在一些实施例中,相邻的旋流部之间设置用于隔离两个旋流部的气流的隔离结构。In some embodiments, an isolation structure for isolating the air flows of the two swirling parts is provided between adjacent swirling parts.

在一些实施例中,隔离结构包括用于为其隔离的两个旋流部中靠近中心的旋流部的气流导流的第一中间导流面和/或用于为其隔离的两个旋流部中靠近边缘的旋流部的气流导流的第二中间导流面。In some embodiments, the isolation structure includes a first intermediate flow guide surface for guiding the airflow of the swirling part close to the center of the two swirling parts for its isolation and/or two swirling parts for isolating it. The second intermediate flow guiding surface of the swirling part near the edge of the flow part to guide the air flow.

在一些实施例中,第一中间导流面至少在气流出口端一侧为截面积从旋流流道的上游至下游逐渐变大的扩张面;和/或,第二中间导流面至少在气流出口端一侧为截面积从旋流流道的上游至下游逐渐变大的扩张面。In some embodiments, the first intermediate guide surface at least on the side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirl flow channel; and/or, the second intermediate guide surface is at least The side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from the upstream to the downstream of the swirl flow channel.

在一些实施例中,第一旋流结构设置于药粉容纳腔的用于引入气流的开口处。In some embodiments, the first swirling structure is arranged at the opening of the powder containing cavity for introducing airflow.

在一些实施例中,吸入给药装置还包括设置于药粉容纳腔与风粉抽吸口之间且用于使风粉混合物产生旋流的第二旋流结构。In some embodiments, the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture.

在一些实施例中,吸入给药装置还包括设置于第一旋流结构和第二旋流结构之间的风粉加速通道;和/或,吸入给药装置还包括设置于第二旋流结构和风粉抽吸口之间的整流结构。In some embodiments, the inhalation drug delivery device further includes an air powder acceleration channel provided between the first swirl structure and the second swirl structure; and/or the inhalation drug delivery device further includes a second swirl structure The rectifying structure between the wind powder suction port.

在一些实施例中,第二旋流结构包括旋流通道和设置于旋流通道内的旋流叶片。In some embodiments, the second swirling structure includes a swirling channel and swirling vanes arranged in the swirling channel.

在一些实施例中,旋流叶片相对于旋流通道固定设置。In some embodiments, the swirl vane is fixedly arranged relative to the swirl channel.

本公开第二方面提供一种吸入给药组合结构,包括药盒和用于抽吸放置于药盒内的药粉的吸入给药装置,药盒具有用于放置药粉的药粉容纳腔,吸入给药装置包括用于引入外部空气的通气口、用于放置药盒的药盒放置腔和用于抽吸药粉容纳腔内的药粉的风粉抽吸口,吸入给药装置还包括设置于通气口与药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构。The second aspect of the present disclosure provides an inhalation drug delivery combination structure, including a medicine box and an inhalation drug delivery device for sucking the powder placed in the medicine box. The medicine box has a powder accommodating cavity for placing the powder. The device includes a vent for introducing outside air, a medicine box placement cavity for placing the medicine box, and an air powder suction port for sucking the medicine powder in the medicine powder accommodating cavity. The inhalation drug delivery device also includes a vent and A first swirling flow structure between the powder accommodating cavities and used for causing the airflow to generate swirling flow before blowing the powder.

在一些实施例中,药盒具有用于引入外部空气的进气口,第一旋流结构设置于进气口处。In some embodiments, the medicine box has an air inlet for introducing external air, and the first swirl structure is disposed at the air inlet.

在一些实施例中,第一旋流结构包括气流入口端、气流出口端和设置于气流入口端和气流出口端之间的旋流通道,旋流通道包括从流道内侧至流道外侧依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。In some embodiments, the first swirl structure includes an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end. The swirl channel includes a swirling channel that surrounds the flow channel from the inner side to the outer side of the flow channel. Two or more swirling parts are arranged, and each swirling part is used to produce a swirling flow of part of the air flow input into it and output it.

在一些实施例中,吸入给药装置还包括设置于药粉容纳腔与风粉抽吸口之间且用于使风粉混合物产生旋流的第二旋流结构。In some embodiments, the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture.

在一些实施例中,第二旋流结构包括旋流通道和设置于旋流通道内的旋流叶片。In some embodiments, the second swirling structure includes a swirling channel and swirling vanes arranged in the swirling channel.

基于本公开提供的吸入给药装置和吸入给药组合结构,吸入给药装置包括用于引入外部空气的通气口、用于放置药盒的药盒放置腔和用于抽吸药盒的药粉容纳腔内的药粉的风粉抽吸口,吸入给药装置还包括设置于通气口与药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构。本公开的吸入给药装置的第一旋流结构使气流在吹送药粉之前产生旋流,更有效地将药粉吹出药粉容纳腔从而优化药粉的抽吸效果。Based on the combined structure of the inhalation drug delivery device and the inhalation drug delivery device provided by the present disclosure, the inhalation drug delivery device includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and a medicine powder container for sucking the medicine box The air powder suction port for the powder in the cavity, and the inhalation drug delivery device further includes a first swirling structure arranged between the vent and the powder containing cavity and used for causing the airflow to generate a swirl before the powder is blown. The first swirling structure of the inhalation drug delivery device of the present disclosure causes the airflow to generate a swirling flow before the powder is blown, and the powder is blown out of the powder containing cavity more effectively, thereby optimizing the suction effect of the powder.

通过以下参照附图对本公开的示例性实施例的详细描述,本公开的其它特征及其优点将会变得清楚。Through the following detailed description of exemplary embodiments of the present disclosure with reference to the accompanying drawings, other features and advantages of the present disclosure will become clear.

附图说明Description of the drawings

此处所说明的附图用来提供对本公开的进一步理解,构成本申请的一部分,本公开的示意性实施例及其说明用于解释本公开,并不构成对本公开的不当限定。在附图中:The drawings described here are used to provide a further understanding of the present disclosure and constitute a part of the present application. The exemplary embodiments of the present disclosure and their descriptions are used to explain the present disclosure, and do not constitute an improper limitation of the present disclosure. In the attached picture:

图1为本公开实施例的吸入给药组合结构的一个角度的立体结构示意图;FIG. 1 is a schematic diagram of a three-dimensional structure of an inhalation drug delivery combination structure of an embodiment of the disclosure;

图2为本公开实施例的吸入给药组合结构的另一个角度的立体结构示意图;2 is a schematic diagram of another perspective three-dimensional structure of the combined structure of inhalation drug delivery according to the embodiments of the disclosure;

图3为图1所示的吸入给药组合结构的分解结构示意图;Figure 3 is a schematic diagram of an exploded structure of the inhalation drug delivery combination structure shown in Figure 1;

图4为图3中盒体的结构示意图;Figure 4 is a schematic diagram of the structure of the box in Figure 3;

图5为图3中第一容纳分体和第二容纳分体的一个角度的结构示意图;FIG. 5 is a schematic structural view of one angle of the first accommodating body and the second accommodating body in FIG. 3;

图6为图3中第一容纳分体和第二容纳分体的另一个角度的结构示意图;FIG. 6 is a schematic structural view of another angle of the first accommodating body and the second accommodating body in FIG. 3;

图7为图3中各第一旋流结构的结构示意图;Fig. 7 is a schematic structural diagram of each first swirl structure in Fig. 3;

图8为图3中一个第一旋流结构的结构示意图;Fig. 8 is a schematic structural diagram of a first swirl structure in Fig. 3;

图9为图3中转盘的结构示意图;Figure 9 is a schematic diagram of the structure of the turntable in Figure 3;

图10为图9所示的转盘的另一个角度的结构示意图;FIG. 10 is a schematic structural diagram of another angle of the turntable shown in FIG. 9;

图11为图3中弹性元件的结构示意图;Figure 11 is a schematic diagram of the structure of the elastic element in Figure 3;

图12为图3中棘爪盘的结构示意图;Figure 12 is a schematic view of the structure of the pawl plate in Figure 3;

图13为图3中安装盘的结构示意图;Figure 13 is a schematic diagram of the structure of the mounting plate in Figure 3;

图14为图3中限位盘的结构示意图;Figure 14 is a schematic diagram of the structure of the limit plate in Figure 3;

图15为图3中转盘外圈的结构示意图;Figure 15 is a schematic diagram of the structure of the outer ring of the turntable in Figure 3;

图16为图3中标志盘的结构示意图;Fig. 16 is a schematic diagram of the structure of the sign disc in Fig. 3;

图17为图3中第一壳体的结构示意图;FIG. 17 is a schematic diagram of the structure of the first housing in FIG. 3;

图18为图3中第二壳体的结构示意图;18 is a schematic diagram of the structure of the second housing in FIG. 3;

图19为图3中气管的结构示意图;Figure 19 is a schematic diagram of the structure of the trachea in Figure 3;

图20为图3中吸嘴的一个方向的结构示意图;Fig. 20 is a schematic structural view of one direction of the suction nozzle in Fig. 3;

图21为图3中吸嘴的另一个方向的结构示意图。Fig. 21 is a schematic structural view of the suction nozzle in Fig. 3 in another direction.

具体实施方式detailed description

下面将结合本公开实施例中的附图,对本公开实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本公开一部分实施例,而不是全部的实施例。以下对至少一个示例性实施例的描述实际上仅仅是说明性的,决不作为对本公开及其应用或使用的任何限制。基于本公开中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本公开保护的范围。The technical solutions in the embodiments of the present disclosure will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present disclosure. Obviously, the described embodiments are only a part of the embodiments of the present disclosure, not all of the embodiments. The following description of at least one exemplary embodiment is actually only illustrative, and in no way serves as any limitation to the present disclosure and its application or use. Based on the embodiments in the present disclosure, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the protection scope of the present disclosure.

除非另外具体说明,否则在这些实施例中阐述的部件和步骤的相对布置、数字表达式和数值不限制本公开的范围。同时,应当明白,为了便于描述,附图中所示出的各个部分的尺寸并不是按照实际的比例关系绘制的。对于相关领域普通技术人员已知的技术、方法和设备可能不作详细讨论,但在适当情况下,所述技术、方法和设备应当被视为授权说明书的一部分。在这里示出和讨论的所有示例中,任何具体值应被解释为仅仅是示例性的,而不是作为限制。因此,示例性实施例的其它示例可以具有不同的值。应注意到:相似的标号和字母在下面的附图中表示类似项,因此,一旦某一项在一个附图中被定义,则在随后的附图中不需要对其进行进一步讨论。Unless specifically stated otherwise, the relative arrangement of components and steps, numerical expressions and numerical values set forth in these embodiments do not limit the scope of the present disclosure. At the same time, it should be understood that, for ease of description, the sizes of the various parts shown in the drawings are not drawn in accordance with actual proportional relationships. The technologies, methods, and equipment known to those of ordinary skill in the relevant fields may not be discussed in detail, but where appropriate, the technologies, methods, and equipment should be regarded as part of the authorization specification. In all examples shown and discussed here, any specific value should be interpreted as merely exemplary, rather than as a limitation. Therefore, other examples of the exemplary embodiment may have different values. It should be noted that similar reference numerals and letters indicate similar items in the following drawings, so once a certain item is defined in one drawing, it does not need to be further discussed in subsequent drawings.

为了便于描述,在这里可以使用空间相对术语,如“在……之上”、“在……上方”、“在……上表面”、“上面的”等,用来描述如在图中所示的一个器件或特征与其他器件或特征的空间位置关系。应当理解的是,空间相对术语旨在包含除了器件在图中所描述的方位之外的在使用或操作中的不同方位。例如,如果附图中的器件被倒置,则描述为“在其他器件或构造上方”或“在其他器件或构造之上”的器件之后将被定位为“在其他器件或构造下方”或“在其他器件或构造之下”。因而,示例性术语“在……上方”可以包括“在……上方”和“在……下方”两种方位。该器件也可以其他不同方式定位(旋转90度或处于其他方位),并且对这里所使用的空间相对描述作出相应解释。For ease of description, spatially relative terms such as "above", "above", "above", "above", etc. can be used here to describe as shown in the figure. Shows the spatial positional relationship between one device or feature and other devices or features. It should be understood that the spatially relative terms are intended to encompass different orientations in use or operation other than the orientation of the device described in the figure. For example, if the device in the figure is inverted, then the device described as "above the other device or structure" or "above the other device or structure" will then be positioned as "below the other device or structure" or "on Under other devices or structures". Thus, the exemplary term "above" can include both orientations "above" and "below". The device can also be positioned in other different ways (rotated by 90 degrees or in other orientations), and the relative description of the space used here is explained accordingly.

本公开实施例的吸入给药装置包括用于引入外部空气的通气口、用于放置药盒的 药盒放置腔和用于抽吸药盒的药粉容纳腔内的药粉的风粉抽吸口。吸入给药装置还包括设置于通气口与药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构。The inhalation drug delivery device of the embodiment of the present disclosure includes a vent for introducing external air, a medicine box placement cavity for placing a medicine box, and an air powder suction port for sucking medicine powder in the medicine powder accommodating cavity of the medicine box. The inhalation drug delivery device also includes a first swirling structure arranged between the vent and the powder accommodating cavity and used for causing the airflow to generate swirl before the powder is blown.

本公开实施例的吸入给药装置通过设置第一旋流结构对冲击药粉之前的气流产生旋流以更有效地将药粉吹出从而提高药粉的抽吸效果。The inhalation drug delivery device of the embodiment of the present disclosure generates a swirling flow on the airflow before impacting the powder by setting the first swirl structure to blow the powder out more effectively, thereby improving the suction effect of the powder.

在一些实施例中,吸入给药装置还包括设置于药粉容纳腔与风粉抽吸口之间且用于使风粉混合物产生旋流的第二旋流结构。第二旋流结构对风粉混合物产生旋流从而使药粉进行充分雾化以提高药粉的吸收率。In some embodiments, the inhalation drug delivery device further includes a second swirling flow structure arranged between the medicinal powder accommodating cavity and the wind powder suction port and used to generate a swirling flow of the wind powder mixture. The second swirling structure generates a swirling flow on the air-powder mixture so that the powder is fully atomized to increase the absorption rate of the powder.

下面根据图1至图21对本实施例的吸入给药装置以及本实施例的吸入给药组合结构的结构进行详细说明。The structure of the inhalation drug delivery device of this embodiment and the combination structure of inhalation drug delivery of this embodiment will be described in detail below based on FIGS. 1 to 21.

本实施例的吸入给药组合结构包括药盒和吸入给药装置。吸入给药装置用于抽吸药盒中的药粉。为了更好地说明本实施例的吸入给药装置的结构,下面先对本实施例的药盒的结构进行详细说明。The combined structure for inhalation administration of this embodiment includes a medicine box and an inhalation administration device. The inhalation drug delivery device is used to suck the powder in the medicine box. In order to better explain the structure of the inhalation drug delivery device of this embodiment, the structure of the medicine box of this embodiment will be described in detail below.

如图1至图8所示,本实施例的药盒包括盒体3和药粉容纳体。药粉容纳体设置于盒体3内且设有用于放置药粉的药粉容纳腔。药粉容纳腔包括用于引入气流的药粉容纳腔第一开口和用于输出风粉混合物的药粉容纳腔第二开口。盒体3上设有用于向盒体3内引入外部空气的进气口3A和用于输出风粉混合物的风粉出口3B。药粉容纳体相对于盒体3可动地设置以使得药粉容纳腔在封闭状态和开放状态之间切换。在封闭状态,盒体3封闭药粉容纳腔第一开口和药粉容纳腔第二开口。在开放状态,药粉容纳腔第一开口与进气口3A连通、药粉容纳腔第二开口与风粉出口3B连通以使药粉能够在风粉出口的抽吸力的作用下与引入进气口的外部空气一起从风粉出口吸出。As shown in Figures 1 to 8, the medicine box of this embodiment includes a box body 3 and a medicine powder containing body. The powder containing body is arranged in the box body 3 and is provided with a powder containing cavity for placing the powder. The powder accommodating cavity includes a first opening of the powder accommodating cavity for introducing airflow and a second opening of the powder accommodating cavity for outputting a mixture of air and powder. The box body 3 is provided with an air inlet 3A for introducing outside air into the box body 3 and an air powder outlet 3B for outputting an air powder mixture. The medicinal powder accommodating body is movably disposed relative to the box body 3 so that the medicinal powder accommodating cavity is switched between a closed state and an open state. In the closed state, the box body 3 seals the first opening of the powder containing cavity and the second opening of the powder containing cavity. In the open state, the first opening of the powder accommodating cavity is in communication with the air inlet 3A, and the second opening of the powder accommodating cavity is in communication with the air powder outlet 3B, so that the powder can interact with the inlet of the air inlet under the suction force of the air powder outlet. The outside air is sucked out from the fan outlet together.

在本实施例中,药粉容纳体相对于盒体3可转动地设置以使得药粉容纳腔在封闭状态和开放状态之间切换。本实施例中药粉容纳体相对于盒体可转动地设置使得药盒的体积较小,利于储存和携带。药粉容纳腔例如可以沿径向设置,或者可以沿轴向设置,也可以与径向成夹角设置或者与轴向成夹角设置等等。In this embodiment, the medicinal powder accommodating body is rotatably disposed relative to the box body 3 so that the medicinal powder accommodating cavity can be switched between a closed state and an open state. In this embodiment, the medicinal powder containing body is rotatably arranged relative to the box body so that the volume of the medicine box is small, which is convenient for storage and carrying. The powder accommodating cavity may be arranged in a radial direction, or may be arranged in an axial direction, or may be arranged at an angle to the radial direction or an angle to the axial direction, for example.

本实施例中,药粉容纳体相对于盒体3同轴且可转动地设置。如图4所示,盒体3包括环形盒体。环形盒体包括第一盒体环壁、第二盒体环壁和形成于第一盒体环壁与第二盒体环壁之间的安装空间。进气口3A设置于第一盒体环壁上,风粉出口3B设置于第二盒体环壁上。药粉容纳体设置于安装空间内。药粉容纳体具有第一容纳体环壁和第二容纳体环壁。药粉容纳腔位于第一容纳体环壁与第二容纳体环壁之间,药粉 容纳腔第一开口设置于第一容纳体环壁上,药粉容纳腔第二开口设置于第二容纳体环壁上。将盒体3设置为环形盒体并将药粉容纳体设置于第一盒体环壁和第二盒体环壁之间的安装空间内使本实施例的药盒的结构紧凑。In this embodiment, the medicinal powder containing body is coaxially and rotatably arranged relative to the box body 3. As shown in Fig. 4, the box body 3 includes an annular box body. The ring-shaped box body includes a first box body ring wall, a second box body ring wall, and an installation space formed between the first box body ring wall and the second box body ring wall. The air inlet 3A is arranged on the annular wall of the first box body, and the air powder outlet 3B is arranged on the annular wall of the second box body. The powder containing body is arranged in the installation space. The medicinal powder container has a first container ring wall and a second container ring wall. The powder accommodating cavity is located between the ring wall of the first accommodating body and the ring wall of the second accommodating body, the first opening of the powder accommodating cavity is provided on the ring wall of the first accommodating body, and the second opening of the powder accommodating cavity is provided on the ring wall of the second accommodating body on. Setting the box body 3 as an annular box body and placing the powder containing body in the installation space between the ring wall of the first box body and the ring wall of the second box body makes the structure of the medicine box of this embodiment compact.

本实施例中,第一盒体环壁为位于环形盒体的径向内侧的盒体内环壁31。第二盒体环壁为位于环形盒体的径向外侧的盒体外环壁32。在其它实施例中,第一盒体环壁可以位于环形盒体的径向外侧,第二盒体环壁可以位于环形盒体的径向内侧。In this embodiment, the first box body ring wall is the box body ring wall 31 located at the radial inner side of the ring box body. The second box body ring wall is the box body ring wall 32 located on the radially outer side of the ring box body. In other embodiments, the first box body ring wall may be located radially outside of the ring box body, and the second box body ring wall may be located radially inside the ring box body.

在一些实施例中,进气口3A和风粉出口3B同方向地设置于盒体3的径向方向上。药粉容纳腔沿药粉容纳体的径向方向延伸。当患者需要抽吸药粉时,控制药粉容纳体相对于盒体3转动以使药粉容纳腔与进气口以及风粉出口连通。当患者不需要抽吸药粉时,控制药粉容纳体相对于盒体3转动以使药粉容纳腔转动至被盒体3封闭的位置。In some embodiments, the air inlet 3A and the air powder outlet 3B are arranged in the same direction in the radial direction of the box body 3. The powder containing cavity extends along the radial direction of the powder containing body. When the patient needs to suck the powder, the powder containing body is controlled to rotate relative to the box body 3 to make the powder containing cavity communicate with the air inlet and the air powder outlet. When the patient does not need to suck the powder, the powder containing body is controlled to rotate relative to the box body 3 so that the powder containing cavity rotates to a position closed by the box body 3.

如图4所示,在本实施例中,环形盒体还包括设置于盒体内环壁31上的第一端壁33,药粉容纳体可转动地连接于第一端壁33上且第一端壁33与盒体内环壁31形成与进气口3A连通的进气腔。进气腔的设置使得吸入给药组合结构的外部空间与进气口3A之间存在空间,利于设置过滤结构、均流结构等附件。As shown in Figure 4, in this embodiment, the annular box body further includes a first end wall 33 arranged on the annular wall 31 of the box body. The powder containing body is rotatably connected to the first end wall 33 and the first end The wall 33 and the inner wall 31 of the box form an air inlet cavity communicating with the air inlet 3A. The arrangement of the air inlet cavity allows a space between the external space of the inhalation and drug delivery combination structure and the air inlet 3A, which facilitates the installation of accessories such as a filter structure and a flow sharing structure.

具体地,环形盒体包括设置于盒体内环壁31与盒体外环壁32之间的第二端壁34。盒体内环壁31、盒体外环壁32和第二端壁34围成环形凹槽,环形凹槽形成安装空间。第二端壁34与第一端壁33设置于盒体3的轴向两端。Specifically, the ring-shaped box body includes a second end wall 34 disposed between the inner ring wall 31 and the outer ring wall 32 of the box body. The ring wall 31 inside the box, the ring wall 32 outside the box and the second end wall 34 enclose an annular groove, and the annular groove forms an installation space. The second end wall 34 and the first end wall 33 are arranged at both axial ends of the box body 3.

在一个附图未示出的实施例中,药粉容纳体也可以相对于盒体可平移地设置。例如,药粉容纳体和盒体均为方体结构,药粉容纳体设置于盒体内且沿盒体的长度方向可平移地设置。In an embodiment that is not shown in the drawings, the medicinal powder containing body may also be arranged translationally relative to the box body. For example, the medicinal powder containment body and the box body are both square structures, and the medicinal powder containment body is arranged in the box body and can be arranged translationally along the length direction of the box body.

在本实施例中,如图5和图6所示,药粉容纳体包括第一容纳分体4和第二容纳分体6。第一容纳分体4上设有第一容纳分腔,第二容纳分体6上设有第二容纳分腔。第一容纳分体4和第二容纳分体6扣合使相应位置的第一容纳分腔与第二容纳分腔共同形成药粉容纳腔。本实施例的药粉容纳体分体设置为两个相互扣合的容纳分体,方便药粉容纳腔的药粉的分装。In this embodiment, as shown in FIGS. 5 and 6, the powder containing body includes a first containing part 4 and a second containing part 6. The first accommodating sub-body 4 is provided with a first accommodating sub-cavity, and the second accommodating sub-body 6 is provided with a second accommodating sub-cavity. The first accommodating part 4 and the second accommodating part 6 are buckled so that the first accommodating cavities and the second accommodating cavities at corresponding positions jointly form a powder accommodating cavity. The powder accommodating body of this embodiment is divided into two accommodating detached bodies that are interlocked with each other to facilitate the dispensing of the powder in the powder accommodating cavity.

本实施例的药粉容纳腔为柱形腔体结构,在其他附图未示出的实施例中,药粉容纳腔也可以设置为其他形状,例如方体结构等。The powder accommodating cavity in this embodiment is a cylindrical cavity structure. In other embodiments not shown in the drawings, the powder accommodating cavity can also be configured in other shapes, such as a square structure.

在一些实施例中,为了使第一容纳分体4和第二容纳分体6之间的扣合更加牢固,第一容纳分体4和第二容纳分体6中的一个上设置有连接柱,另一个上设置有连接孔,连接柱穿设于连接孔中以使第一容纳分体4和第二容纳分体6相互紧密地扣合。In some embodiments, in order to make the fastening between the first accommodating body 4 and the second accommodating body 6 more firm, a connecting post is provided on one of the first accommodating body 4 and the second accommodating body 6 , The other is provided with a connecting hole, and the connecting post is penetrated through the connecting hole so that the first accommodating body 4 and the second accommodating body 6 are tightly buckled with each other.

具体在本实施例中,如图5和图6所示,第一容纳分体4上既设置有连接柱,也设置有连接孔,相应地,第二容纳分体6上既设置与第一容纳分体4上设置的连接孔配合的连接柱,也设置有与第一容纳分体4上设置的连接柱配合的连接孔。如此设置使第一容纳分体4和第二容纳分体6之间的装配更加紧密。Specifically in this embodiment, as shown in Figures 5 and 6, the first accommodating body 4 is provided with both a connecting column and a connecting hole. Accordingly, the second accommodating body 6 is provided with both a connecting column and a connecting hole. The connecting post matched with the connecting hole provided on the receiving split body 4 is also provided with a connecting hole matched with the connecting post provided on the first receiving split body 4. This arrangement makes the assembly between the first accommodating body 4 and the second accommodating body 6 closer.

本实施例的连接柱为圆形结构,连接孔为方形结构。如此设置方便药粉容纳体的组合。The connecting column in this embodiment has a circular structure, and the connecting hole has a square structure. This arrangement facilitates the combination of the powder container.

具体地,本实施例的第一容纳分体4为环形结构且套设于盒体3的盒体内环壁31的外侧。第二容纳分体6与第一容纳分体4扣合且设置于第一端壁33上。如图4所示,第一端壁33上设置有通孔33A。第二容纳分体6上设置有转动轴6A,转动轴6A穿设于通孔33A中以使第二容纳分体6相对于盒体3可转动,由于第一容纳分体4与第二容纳分体6相互连接,因此第二容纳分体6相对于盒体3转动可带动第一容纳分体4同步转动。Specifically, the first accommodating sub-body 4 of this embodiment has a ring structure and is sleeved on the outside of the ring wall 31 of the box body 3. The second accommodating part 6 is buckled with the first accommodating part 4 and arranged on the first end wall 33. As shown in FIG. 4, the first end wall 33 is provided with a through hole 33A. The second accommodating body 6 is provided with a rotating shaft 6A, and the rotating shaft 6A penetrates through the through hole 33A to make the second accommodating body 6 rotatable relative to the box body 3, because the first accommodating body 4 and the second accommodating body The split bodies 6 are connected to each other, so that the rotation of the second accommodating split body 6 relative to the box body 3 can drive the first accommodating split body 4 to rotate synchronously.

本实施例的药粉容纳体包括两个以上药粉容纳腔。本实施例的药盒的两个以上的药粉容纳腔可容纳多剂药粉,患者在使用本实施例的药盒进行吸入给药时,可以通过控制药粉容纳体相对于盒体3转动以使得两个以上药粉容纳腔依次处于开放状态进而依次抽吸不同药粉容纳腔中的药粉。此时两个以上药粉容纳腔中可以放置不同种类的药粉,也可以放置相同种类的药粉。例如,当两个以上药粉容纳腔中放置相同种类的药粉时,患者可以根据药粉的用量来依次抽吸不同药粉容纳腔中的药粉以实现定量用药。当两个以上药粉容纳腔中放置不同种类的药粉时,患者可以根据不同药粉的用量来抽吸。因此本实施例的药盒方便患者用药。The powder containing body of this embodiment includes more than two powder containing cavities. The two or more powder-containing cavities of the medicine box of this embodiment can contain multiple doses of powder. When the patient uses the medicine box of this embodiment for inhalation, he can control the powder-containing body to rotate relative to the box body 3 so that the two More than one medicated powder accommodating cavities are sequentially in an open state, and the medicinal powders in different medicated powder accommodating cavities are sequentially sucked. At this time, two or more medicated powder containing cavities can be placed in different types of medicated powder, or the same type of medicated powder can be placed. For example, when two or more medicated powder containing cavities are placed in the same type of medicated powder, the patient can sequentially suck the medicated powder in different powdered accommodating cavities according to the amount of the powdered powder to achieve quantitative medication. When two or more medicated powder accommodating cavities are placed in different types of medicated powder, the patient can inhale according to the dosage of the different medicated powder. Therefore, the medicine box of this embodiment is convenient for patients to take medicine.

图5和图6示意性地示出药盒的药粉容纳体具有七个药粉容纳腔,药粉容纳体相对于盒体3可转动地设置使得七个药粉容纳腔依次与进气口3A和风粉出口3B连通。Figures 5 and 6 schematically show that the powder containing body of the medicine box has seven powder containing cavities. The powder containing body is rotatably arranged relative to the box body 3 so that the seven powder containing cavities are connected to the air inlet 3A and the air powder outlet in sequence. 3B is connected.

如图17至图21所示,本实施例的吸入给药装置包括用于装设药盒的壳体和吸嘴16。壳体上设置有上述用于引入外部空气的通气口和用于放置药盒的药盒放置腔。吸嘴16具有用于抽吸药盒内的药粉的风粉抽吸口。具体地,如图20和图21所示,本实施例的吸嘴16具有风粉抽吸通道和设置于风粉抽吸通道的远离药盒一端的风粉抽吸口16A。As shown in Figures 17 to 21, the inhalation drug delivery device of this embodiment includes a housing and a suction nozzle 16 for installing a medicine box. The casing is provided with the aforementioned vent for introducing external air and a medicine box placing cavity for placing the medicine box. The suction nozzle 16 has an air powder suction port for sucking the powder in the medicine box. Specifically, as shown in FIG. 20 and FIG. 21, the suction nozzle 16 of this embodiment has an air powder suction channel and an air powder suction port 16A disposed at an end of the air powder suction channel away from the medicine box.

如图1、图2、图17和图18所示,本实施例的壳体包括第一壳体1和第二壳体2。第一壳体1上设置有用于引入外部空气的通气口1A。第二壳体2具有药盒放置腔。药盒放置腔具有与通气口1A连通的第一药盒放置腔开口2A。第一药盒放置腔开口2A 与药盒的盒体的进气口3A连通以向盒体3内引入外部空气。本实施例的药盒放置腔还具有与风粉抽吸口连通的第二药盒放置腔开口。患者通过吸嘴16的风粉抽吸通道从风粉出口处抽吸药粉。As shown in FIGS. 1, 2, 17 and 18, the housing of this embodiment includes a first housing 1 and a second housing 2. The first housing 1 is provided with a vent 1A for introducing outside air. The second housing 2 has a medicine box placement cavity. The medicine box placement cavity has a first medicine box placement cavity opening 2A communicating with the vent 1A. The first medicine box placement cavity opening 2A communicates with the air inlet 3A of the box body of the medicine box to introduce outside air into the box body 3. The medicine box placement cavity of this embodiment also has a second medicine box placement cavity opening communicating with the air powder suction port. The patient sucks the powder from the wind powder outlet through the wind powder suction channel of the suction nozzle 16.

在一些实施例中,为了对进入壳体内的空气进行过滤,如图17所示,本实施例的第一壳体1的通气口1A处设有过滤结构。并且本实施例的第二壳体的第一药盒放置腔开口2A处设有均流结构。In some embodiments, in order to filter the air entering the housing, as shown in FIG. 17, the vent 1A of the first housing 1 of this embodiment is provided with a filtering structure. In addition, the opening 2A of the first medicine box placement cavity of the second casing of this embodiment is provided with a flow-sharing structure.

具体地,本实施例的吸嘴16包括用于将吸嘴16安装于壳体上的吸嘴本体161和口腔含入部162。口腔含入部162上设置有上述风粉抽吸口16A以为药粉抽吸提供抽吸力。患者在使用本实施例的吸入给药组合结构时,只要将口腔含入部162含入口中并用力吸气就可以将药粉抽吸进入体内。Specifically, the suction nozzle 16 of this embodiment includes a nozzle body 161 and an oral cavity 162 for mounting the suction nozzle 16 on the housing. The oral cavity 162 is provided with the above-mentioned air-powder suction port 16A to provide suction force for sucking the powder. When the patient uses the combined structure for inhalation and administration of this embodiment, the oral cavity 162 can be sucked into the body by putting the oral cavity 162 into the mouth and inhaling hard.

由于吸嘴16需要直接与患者的口腔进行接触,为了防止吸嘴16污染,本实施例的吸入给药装置还包括设置于吸嘴16外侧的吸嘴盖18。Since the suction nozzle 16 needs to be in direct contact with the patient's oral cavity, in order to prevent the suction nozzle 16 from being contaminated, the inhalation drug delivery device of this embodiment further includes a suction nozzle cover 18 provided outside the suction nozzle 16.

在一些实施例中,为了使药粉充分雾化,本实施例的吸入给药装置还包括设置于通气口1A与药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构5。In some embodiments, in order to fully atomize the medicinal powder, the inhalation drug delivery device of this embodiment further includes a first swirler arranged between the vent 1A and the medicinal powder accommodating cavity and used to cause the airflow to generate a swirl before the powder is blown. Flow structure 5.

在一些实施例中,第一旋流结构包括气流入口端、气流出口端和设置于所述气流入口端和所述气流出口端之间的旋流通道,所述旋流通道包括从流道中心至流道边缘依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。第一旋流结构使得气流在吹送药粉之前产生旋流而使药粉充分雾化,从而加大被吸入肺部的药粉的比例。In some embodiments, the first swirling structure includes an airflow inlet end, an airflow outlet end, and a swirling channel disposed between the airflow inlet end and the airflow outlet end, and the swirling channel includes a flow path from the center of the flow channel. Two or more swirling parts are arranged around the edge of the flow channel in turn, and each swirling part is used to generate a swirling flow of part of the airflow input into it and output it. The first swirling structure causes the airflow to generate a swirling flow before blowing the powder to make the powder fully atomized, thereby increasing the proportion of the powder being inhaled into the lungs.

如图3、图7和图8所示,本实施例的第一旋流结构5设置于药粉容纳腔第一开口的上游。而且本实施例的第一旋流结构5为圆形结构。在药粉容纳腔第一开口的上游设置第一旋流结构5使得气流在吹送药粉之前产生旋流而增大药粉的抽吸量,从而加大被吸入肺部的药粉的比例。如图7所示,本实施例的药盒包括与两个以上药粉容纳腔对应设置的两个以上第一旋流结构5。为了便于装配,两个以上第一旋流结构5可以连接在一起。As shown in Fig. 3, Fig. 7 and Fig. 8, the first swirling structure 5 of this embodiment is arranged upstream of the first opening of the powder containing cavity. Moreover, the first swirl structure 5 of this embodiment is a circular structure. A first swirling structure 5 is arranged upstream of the first opening of the powder accommodating cavity so that the airflow generates swirl before blowing the powder to increase the suction volume of the powder, thereby increasing the proportion of the powder being inhaled into the lungs. As shown in FIG. 7, the medicine box of this embodiment includes two or more first swirling structures 5 corresponding to two or more powder containing cavities. To facilitate assembly, two or more first swirl structures 5 can be connected together.

如图8所示,本实施例的第一旋流结构5具有气流入口端、气流出口端和设置于气流入口端和气流出口端之间的旋流通道。旋流通道包括从流道的径向内侧至流道的径向外侧依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。本实施例的第一旋流结构5通过在旋流通道内设置环绕布置的两个以 上旋流部,使得处于旋流通道的在流道的径向内侧到流道的径向外侧之间的不同位置的气流均能产生旋流,因此位于整个流道内不同位置的气流均能产生旋流,增大药粉的抽吸量。As shown in Fig. 8, the first swirl structure 5 of this embodiment has an air inlet end, an air outlet end, and a swirl channel arranged between the air inlet end and the air outlet end. The swirling channel includes two or more swirling parts arranged sequentially from the radially inner side of the flow channel to the radially outer side of the flow channel, and each swirling part is used to generate a swirling flow of a part of the airflow input into it and output it. In the first swirl structure 5 of this embodiment, two or more swirling parts are arranged in the swirl channel, so that the difference between the radial inner side of the flow channel and the radial outer side of the flow channel of the swirl channel is different. The airflow at different positions can produce swirling flow, so the airflows at different positions in the entire flow channel can produce swirling flow, which increases the suction volume of powder.

如图8所示,本实施例的第一旋流结构5包括第一旋流部51和第二旋流部52。而且第一旋流部51和第二旋流部52产生的旋流的方向相反。本实施例的药盒将相邻的旋流部产生的旋流的方向设置为反向,使得在吹送药粉之前的气流形成不同方向的旋流,从而对药粉的冲击力的方向也不同,因此可以更好地将药粉雾化为较小的粉体,更易于被患者吸收。As shown in FIG. 8, the first swirling structure 5 of this embodiment includes a first swirling portion 51 and a second swirling portion 52. In addition, the directions of the swirling flows generated by the first swirling part 51 and the second swirling part 52 are opposite. The medicine box of this embodiment sets the direction of the swirling flow generated by the adjacent swirling parts to be reversed, so that the airflow before blowing the medicine powder forms a swirling flow of different directions, so that the direction of the impact force on the medicine powder is also different. It can better atomize the medicine powder into a smaller powder, which is easier to be absorbed by the patient.

在本实施例中,第一旋流结构5设置于进气口3A处。为了利于保证药粉容纳腔的密封性并使进入药粉容纳腔中的气流更集中,第一旋流结构5的气流入口端的端面与药盒的进气口处的端面接触并形状配合。本实施例的第一旋流结构5设置于盒体3的进气口3A处,第一旋流结构5的气流入口端的端面与盒体3接触配合,第一旋流结构5的气流出口端的端面与药粉容纳体接触配合。In this embodiment, the first swirl structure 5 is arranged at the air inlet 3A. In order to help ensure the sealing of the powder accommodating cavity and to make the air flow into the powder accommodating cavity more concentrated, the end surface of the air inlet end of the first swirl structure 5 is in contact with the end surface of the air inlet of the medicine box and is shape-matched. The first swirling structure 5 of this embodiment is arranged at the air inlet 3A of the box body 3. The end surface of the airflow inlet end of the first swirling structure 5 is in contact with the box body 3, and the airflow outlet end of the first swirling structure 5 is The end surface is in contact with the powder containing body.

在其他实施例中,第一旋流结构也可以设置于通气口与药粉容纳腔之间的气流通道上的其他位置。例如,第一旋流结构也可以设置于第一药盒放置腔开口处。In other embodiments, the first swirling structure may also be arranged at other positions on the airflow channel between the vent and the powder containing cavity. For example, the first swirl structure may also be arranged at the opening of the first medicine box placement cavity.

在本实施例中,盒体3的第一盒体环壁为柱面结构,因此如图8所示,第一旋流结构5的气流入口端的端面设置为向气流出口端一侧凸出的柱面弧形结构。In this embodiment, the first box body ring wall of the box body 3 has a cylindrical structure. Therefore, as shown in FIG. 8, the end surface of the air inlet end of the first swirl structure 5 is set to protrude toward the air outlet end side. Cylindrical arc structure.

在一些实施例中,第一旋流结构5还包括设置于从流道外侧数第一个旋流部外侧的外侧导流面。外侧导流面至少在气流出口端一侧为从旋流通道的上游至下游逐渐变大的扩张面。外侧导流面设置为扩张面利于使气流对位于药粉容纳腔的腔壁处的药粉进行冲击,从而减少药粉残留,增大进入患者口腔内的药粉量。In some embodiments, the first swirl structure 5 further includes an outer flow guide surface arranged on the outside of the first swirl part counted from the outside of the flow channel. The outer guide surface is an expansion surface that gradually increases from the upstream to the downstream of the swirling channel at least on the side of the air outlet end. The setting of the outer diversion surface as an expanded surface facilitates the airflow to impact the powder located at the cavity wall of the powder containing cavity, thereby reducing the residual powder and increasing the amount of powder entering the patient's oral cavity.

具体在本实施例中,扩张面包括锥面结构。Specifically, in this embodiment, the expansion surface includes a tapered surface structure.

在一些实施例中,为了避免相邻两个旋流部之间的气流互相影响,如图8所示,本实施例的相邻的旋流部之间设置用于隔离两个旋流部的气流的隔离结构53。In some embodiments, in order to avoid the mutual influence of the airflow between two adjacent swirling parts, as shown in FIG. 8, the adjacent swirling parts of this embodiment are provided between the two adjacent swirling parts. Airflow isolation structure 53.

在一些实施例中,隔离结构53包括用于为其隔离的两个旋流部中内侧的旋流部的气流导流的第一中间导流面和用于为其隔离的两个旋流部中外侧的旋流部的气流导流的第二中间导流面。In some embodiments, the isolation structure 53 includes a first intermediate flow guide surface for guiding the airflow of the inner swirling part of the two swirling parts for isolation, and two swirling parts for isolating it. The second middle guide surface for guiding the airflow of the middle and outer swirling parts.

具体地,第一中间导流面至少在气流出口端一侧为截面积从旋流流道的上游至下游逐渐变大的扩张面,且第二中间导流面至少在气流出口端一侧为截面积从旋流流道的上游至下游逐渐变大的扩张面。扩张面的设置同样可以使气流对位于药粉容纳腔的 腔壁处的药粉进行冲击,从而增大进入患者口腔内的药粉量。本实施例的吸入给药装置通过设置第一旋流结构使气流在吹送药粉之前产生旋流而使药粉充分雾化,从而加大被吸入肺部的药粉的比例。Specifically, the first intermediate guide surface at least on the side of the air outlet end is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirl flow channel, and the second intermediate guide surface is at least on the side of the air outlet end. The cross-sectional area gradually increases from the upstream to the downstream of the swirl flow channel. The arrangement of the expansion surface can also make the air flow impact the powder located on the wall of the powder containing cavity, thereby increasing the amount of powder entering the patient's oral cavity. The inhalation drug delivery device of this embodiment is provided with a first swirl structure to cause the airflow to swirl before blowing the powder to make the powder fully atomized, thereby increasing the proportion of the powder being inhaled into the lungs.

为了更好地对药粉进行雾化,如图20和图21所示,本实施例的吸入给药装置还包括设置于药粉容纳腔与风粉抽吸口之间且用于使风粉混合物产生旋流的第二旋流结构19。本实施例的吸入给药装置通过设置对冲击药粉之前的气流产生旋流的第一旋流结构5和对风粉混合物产生旋流的第二旋流结构19对药粉进行充分雾化以提高药粉的吸收率。In order to better atomize the powder, as shown in FIG. 20 and FIG. 21, the inhalation drug delivery device of this embodiment also includes a device that is arranged between the powder accommodating cavity and the air powder suction port and is used to generate the air powder mixture. The swirling second swirling structure 19. The inhalation drug delivery device of this embodiment is provided with a first swirling structure 5 that generates a swirling flow on the airflow before impacting the powder and a second swirling structure 19 that swirls the wind and powder mixture to fully atomize the powder to improve the powder. The absorption rate.

在本实施例中,第二旋流结构19设置于风粉抽吸通道上。第二旋流结构19使风粉出口的风粉混合物在通过风粉抽吸通道时产生旋流进而进一步雾化,从而提高药粉的雾化效果,进一步提高患者对药粉的吸收率。In this embodiment, the second swirl structure 19 is arranged on the air powder suction channel. The second swirling structure 19 causes the air-powder mixture at the air-powder outlet to generate a swirling flow when passing through the air-powder suction channel and further atomize, thereby improving the atomization effect of the medicinal powder and further improving the patient's absorption rate of the medicinal powder.

第二旋流结构19包括旋流通道和设置于旋流通道内的旋流叶片。在本实施例中,风粉抽吸通道形成第二旋流结构的旋流通道。The second swirling structure 19 includes a swirling passage and swirling vanes arranged in the swirling passage. In this embodiment, the air and powder suction channel forms a swirling channel of the second swirling structure.

具体地,旋流叶片相对于旋流通道固定设置。该设置有利于维持每次吸入的药粉量的稳定。Specifically, the swirling blade is fixedly arranged relative to the swirling passage. This setting helps to maintain the stability of the amount of powder inhaled each time.

在其他附图未示出的实施例中,第一旋流结构也可以包括旋流通道和设置于旋流通道内的旋流叶片。同样地,第二旋流结构也可以包括气流入口端、气流出口端和设置于所述气流入口端和所述气流出口端之间的旋流通道,所述旋流通道包括从流道中心至流道边缘依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。In other embodiments not shown in the drawings, the first swirling structure may also include swirling channels and swirling vanes arranged in the swirling channels. Similarly, the second swirling flow structure may also include an airflow inlet end, an airflow outlet end, and a swirling channel arranged between the airflow inlet end and the airflow outlet end, and the swirling channel includes a flow path from the center to Two or more swirling parts are arranged around the edge of the flow channel in turn, and each swirling part is used to generate a swirling flow of part of the airflow input into it and output it.

本实施例的吸嘴16还包括设置于吸嘴本体161与壳体之间的气管15。气管15通过气管连接部17连接于壳体上。气管15的内腔形成部分风粉抽吸通道。The suction nozzle 16 of this embodiment further includes an air pipe 15 provided between the nozzle body 161 and the housing. The trachea 15 is connected to the housing through a trachea connecting portion 17. The inner cavity of the trachea 15 forms part of the air powder suction channel.

在一些实施例中,气管15内设置有用于对风粉混合物进行整流的整流结构151。In some embodiments, the air pipe 15 is provided with a rectifying structure 151 for rectifying the air and powder mixture.

在本实施例中,第二旋流结构19设置于整流结构151的下游,也就是说整流结构151设置于第一旋流结构5与第二旋流结构19之间。因此气流在吹送药粉之前产生旋流后与药粉进行混合形成风粉混合物。在形成风粉混合物后先通过整流结构151进行整流使风粉混合物在整个风粉抽吸通道内平稳流动,然后再通过第二旋流结构19对整个风粉抽吸通道内的风粉混合物进行旋流,可以使更多的风粉混合物进行旋流,使药粉进行充分雾化。In this embodiment, the second swirling structure 19 is arranged downstream of the rectifying structure 151, that is, the rectifying structure 151 is arranged between the first swirling structure 5 and the second swirling structure 19. Therefore, the airflow generates a swirling flow before blowing the powder, and then mixes with the powder to form a wind powder mixture. After the air and powder mixture is formed, the air and powder mixture is rectified through the rectifying structure 151 to make the air and powder mixture flow smoothly in the entire air and powder suction channel, and then the air and powder mixture in the entire air and powder suction channel is processed through the second swirl structure 19 The swirling flow can make more air and powder mixture swirl, so that the powder can be fully atomized.

在一些实施例中,为了使从药盒吹出的药粉进行加速,本实施例的吸入给药装置 还包括设置于第一旋流结构5和第二旋流结构19之间的风粉加速通道。该风粉加速通道使得药粉在气流的带动下可以充分加速从而使药粉以较快的速度进入到第二旋流结构中以有效打散药粉进行充分雾化。In some embodiments, in order to accelerate the powder blown out of the medicine box, the inhalation drug delivery device of this embodiment further includes a wind powder acceleration channel arranged between the first swirling structure 5 and the second swirling structure 19. The air-powder acceleration channel enables the medicinal powder to be fully accelerated under the driving of the airflow, so that the medicinal powder enters the second swirling structure at a relatively fast speed to effectively disperse the medicinal powder for full atomization.

在本实施例中风粉加速通道为设置于第一旋流结构5与第二旋流结构19之间的加速腔。该加速腔为药粉的加速提供了空间,从而使药粉在进入到第二旋流结构时可以具有较快的速度。In this embodiment, the wind and powder acceleration channel is an acceleration cavity provided between the first swirl structure 5 and the second swirl structure 19. The acceleration cavity provides a space for the acceleration of the powder, so that the powder can have a faster speed when it enters the second swirl structure.

在一些实施例中,该加速腔的长度大于等于10mm。In some embodiments, the length of the acceleration cavity is greater than or equal to 10 mm.

在一些实施例中,加速腔的长度大于20mm。In some embodiments, the length of the acceleration cavity is greater than 20 mm.

在一些实施例中,本实施例的口腔含入部162还具有设置于风粉抽吸口16A一侧并与大气连通以在风粉抽吸口16A的外侧形成周边风的周边风抽吸口16B。周边风抽吸口16B的设置使得在风粉抽吸口16A的外侧形成周边风,因此药粉在通过口腔时,在药粉的流通主通道的外侧的周边风对药粉形成一定的隔离作用,使药粉较难粘附于口腔壁上,因此提高进入肺部给药的药粉的比例。In some embodiments, the oral cavity 162 of this embodiment further has a peripheral wind suction port 16B that is provided on the side of the air powder suction port 16A and communicates with the atmosphere to form peripheral wind outside the air powder suction port 16A. . The peripheral air suction port 16B is arranged so that peripheral air is formed outside the air powder suction port 16A. Therefore, when the powder passes through the oral cavity, the peripheral air outside the main channel of the powder circulation forms a certain isolation effect on the powder, so that the powder It is more difficult to adhere to the oral cavity wall, so the proportion of powder that enters the lungs is increased.

在本实施例中,第一壳体1与第二壳体2之间形成气体容纳空间。通过第一壳体1的通气口1A进入第一壳体1内的气体部分通过第二壳体上的第一药盒放置腔开口进入药盒内,部分进入第一壳体1与第二壳体2之间形成的气体容纳空间内。吸嘴16设置于壳体上。且吸嘴16的风粉抽吸口16A通过风粉抽吸通道与第二壳体上的第二药盒放置腔开口连通以抽吸药粉。吸嘴16的位于风粉抽吸口的一侧的周边风抽吸口16B与气体容纳空间连通以与大气连通从而形成周边风。In this embodiment, a gas containing space is formed between the first housing 1 and the second housing 2. Part of the gas entering the first housing 1 through the vent 1A of the first housing 1 enters the medicine box through the opening of the first medicine box placement cavity on the second housing, and partly enters the first housing 1 and the second housing In the gas containing space formed between the bodies 2. The suction nozzle 16 is arranged on the housing. In addition, the air powder suction port 16A of the suction nozzle 16 communicates with the opening of the second medicine box placement cavity on the second housing through the air powder suction channel to suck the powder. The peripheral wind suction port 16B of the suction nozzle 16 located on the side of the wind powder suction port communicates with the gas storage space to communicate with the atmosphere to form peripheral wind.

如图17和图18所示,第一壳体1的过滤结构上设置有向第一壳体1的内侧延伸的支撑部1B。第二壳体2与第一壳体1扣合时,支撑部1B使第二壳体2与第一壳体1之间具有间隙,因此第二壳体2的药盒放置腔的外侧面与第一壳体1之间形成气体容纳空间。吸嘴16安装于壳体上时,吸嘴16的周边风抽吸口可以抽吸到气体容纳空间内的气体从而形成周边风。As shown in FIGS. 17 and 18, the filter structure of the first housing 1 is provided with a support portion 1B extending toward the inner side of the first housing 1. When the second housing 2 is buckled with the first housing 1, the support portion 1B provides a gap between the second housing 2 and the first housing 1. Therefore, the outer surface of the medicine box placement cavity of the second housing 2 and A gas containing space is formed between the first housing 1. When the suction nozzle 16 is installed on the housing, the peripheral wind suction port of the suction nozzle 16 can suck the gas in the gas containing space to form the peripheral wind.

在一些实施例中,口腔含入部162上设置有位于风粉抽吸口16A周向上不同位置的至少两个周边风抽吸口16B。如此设置可以增加周边风的出风点,更好地防止药粉粘附于口腔壁上。In some embodiments, the oral cavity 162 is provided with at least two peripheral wind suction ports 16B located at different positions in the circumferential direction of the wind powder suction port 16A. This arrangement can increase the outlet point of the surrounding wind and better prevent the powder from sticking to the oral cavity wall.

为了使风粉抽吸口16A外侧的周边风均衡,以使药粉在进入口腔内的流通方向不会发生较大的偏移,本实施例的风粉抽吸口16A的两侧对称设有两个周边风抽吸口16B。In order to balance the peripheral wind on the outside of the air powder suction port 16A so that the flow direction of the powder entering the oral cavity will not be greatly deviated, the air powder suction port 16A of this embodiment is provided with two symmetrical sides on both sides. Peripheral wind suction ports 16B.

在一个附图未示出的实施例中,至少两个周边风抽吸口还可以围绕风粉抽吸口设置。如此设置使得风粉抽吸通道的周向上均形成周边风,更全方位地防止药粉粘附于口腔壁上。In an embodiment not shown in the figure, at least two peripheral air suction openings may also be arranged around the air powder suction opening. Such arrangement makes the peripheral wind formed in the circumferential direction of the wind powder suction channel, and prevents the powder from adhering to the oral cavity wall in all directions.

口腔含入部162包括抽吸时位于口腔一侧的抽吸端面。风粉抽吸口16A和周边风抽吸口16B均设置于抽吸端面上。The oral cavity 162 includes a suction end surface located on one side of the oral cavity during suction. The air powder suction opening 16A and the peripheral air suction opening 16B are both arranged on the suction end surface.

本实施例的抽吸端面包括向远离口腔一侧凸出的曲面。该曲面形成凹入空间以方便口腔含入部有效贴合口唇防止口腔侧露并尽量避让舌头,防止药粉粘附于口腔和舌头上。The suction end surface of this embodiment includes a curved surface protruding to the side away from the oral cavity. The curved surface forms a recessed space to facilitate the oral cavity to effectively fit the lips to prevent the side of the oral cavity from showing, and to avoid the tongue as much as possible to prevent the powder from adhering to the oral cavity and the tongue.

具体在本实施例中,曲面为弧形柱面。Specifically, in this embodiment, the curved surface is an arc cylindrical surface.

为了使从风粉抽吸通道进入口腔内的药粉的流通方向不发生偏移,本实施例的口腔含入部包括位于风粉抽吸口的两端的两个周边风抽吸口,且两个周边风抽吸口的中心与风粉抽吸口的中心均位于平行于弧形柱面的母线的同一直线上。In order to prevent the flow direction of the medicinal powder entering the oral cavity from shifting from the air powder suction channel, the oral cavity of this embodiment includes two peripheral air suction openings located at both ends of the air powder suction opening, and The center of the wind suction port and the center of the wind powder suction port are both located on the same straight line parallel to the generatrix of the arc cylindrical surface.

为了提高患者使用本实施例的吸入给药组合结构的便利性,本实施例的吸入给药装置包括用于驱动药粉容纳体相对于盒体3运动的驱动机构。In order to improve the convenience for patients to use the combined structure of inhalation drug delivery in this embodiment, the inhalation drug delivery device of this embodiment includes a driving mechanism for driving the powder container to move relative to the box body 3.

在本实施例中,驱动机构包括相对于盒体3可转动的棘爪盘9。棘爪盘9上设置有棘爪盘棘爪91。药粉容纳体上设置有容纳体棘齿。棘爪盘棘爪91驱动容纳体棘齿转动以带动药粉容纳体转动。In this embodiment, the driving mechanism includes a pawl plate 9 rotatable relative to the box body 3. The pawl plate 9 is provided with a pawl plate pawl 91. The medicine powder container is provided with container ratchets. The pawl disc pawl 91 drives the ratchet tooth of the container to rotate to drive the powder container to rotate.

具体地,如图5所示,药粉容纳体的第二容纳分体6的顶面上设置有容纳体棘齿61。安装有棘爪盘棘爪91的棘爪盘9安装于安装盘7上并与设置于药粉容纳体上的容纳体棘齿进行配合以驱动第二容纳分体6转动。第二容纳分体6与第一容纳分体4连接,因此第一容纳分体4也可随着第二容纳分体6同步转动进而实现药粉容纳体的转动。Specifically, as shown in FIG. 5, a container ratchet 61 is provided on the top surface of the second container body 6 of the powder container. The pawl plate 9 equipped with the pawl plate pawl 91 is installed on the mounting plate 7 and cooperates with the container ratchet provided on the powder container to drive the second container body 6 to rotate. The second accommodating body 6 is connected to the first accommodating body 4, so the first accommodating body 4 can also rotate synchronously with the second accommodating body 6 to realize the rotation of the powder accommodating body.

如图13所示,安装盘7上设置有沿周向间隔设置的多个连接条71。棘爪盘9上设置有多个连接凸起92。连接条71卡设于两个连接凸起92之间以将棘爪盘安装于安装盘7上。As shown in FIG. 13, the mounting plate 7 is provided with a plurality of connecting bars 71 arranged at intervals in the circumferential direction. A plurality of connecting protrusions 92 are provided on the pawl plate 9. The connecting bar 71 is clamped between the two connecting protrusions 92 to install the pawl plate on the mounting plate 7.

为了方便操作,如图9所示,本实施例中的吸入给药组合结构还包括设置有旋钮的转盘13。棘爪盘9与转盘13连接以在转盘13的带动下同步转动。In order to facilitate operation, as shown in FIG. 9, the combined structure for inhalation and drug delivery in this embodiment further includes a turntable 13 provided with a knob. The pawl plate 9 is connected with the turntable 13 to rotate synchronously under the drive of the turntable 13.

在一个附图未示出的实施例中,可以直接使转盘棘爪与容纳体棘齿进行配合进而驱动药粉容纳体转动。In an embodiment not shown in the drawings, the pawl of the turntable can be directly matched with the ratchet teeth of the container to drive the powder container to rotate.

为了便于获取本实施例的药盒的使用信息,本实施例的吸入给药装置还包括用于 显示药盒的使用信息的信息显示结构。In order to facilitate obtaining the use information of the medicine box of this embodiment, the inhalation drug delivery device of this embodiment further includes an information display structure for displaying the use information of the medicine box.

药粉容纳体包括两个以上药粉容纳腔。信息显示结构包括与两个以上药粉容纳腔对应设置的两个以上标志的标志盘8。标志盘8与药粉容纳体同步转动。如图15和图16所示,本实施例的吸入给药组合结构包括标志盘8和转盘外圈10。转盘外圈10相对于盒体3固定设置。转盘外圈10上设置有窗口10A。标志盘8设置于转盘外圈10的下侧。标志盘8在转动的过程中窗口10A可以显示标志盘8上的标志。而且如图1所示,转盘13设置于转盘外圈10的中部,转盘外圈10上设置有箭头以示出转盘13转动的方向。The powder containing body includes more than two powder containing cavities. The information display structure includes two or more flag plates 8 corresponding to two or more powder containing cavities. The marking disc 8 rotates synchronously with the powder containing body. As shown in FIG. 15 and FIG. 16, the combined structure of inhalation drug delivery in this embodiment includes a marker disk 8 and a turntable outer ring 10. The turntable outer ring 10 is fixedly arranged relative to the box body 3. A window 10A is provided on the outer ring 10 of the turntable. The marking plate 8 is provided on the lower side of the outer ring 10 of the turntable. The window 10A can display the marks on the sign disc 8 while the sign disc 8 is rotating. Moreover, as shown in FIG. 1, the turntable 13 is arranged in the middle of the outer ring 10 of the turntable, and an arrow is provided on the outer ring 10 to show the direction in which the turntable 13 rotates.

在本实施例中,如图16所示,标志盘8上设置有与两个以上药粉容纳腔对应设置的计数标志。标志盘8相对于药粉容纳体同步转动以显示药粉容纳体内多个药粉容纳腔的药粉的使用情况。例如,对于本实施例的药盒,具有七个药粉容纳腔。在本实施例的药盒未使用时,标志盘8计数标志显示为零。随着药盒内药粉容纳腔中药粉的逐渐使用,标志盘8的计数标志逐渐变大。当标志盘8上的计数标志到达七时,患者即可知道药盒内的药粉已全部用完,可以更换新的药盒使用。标志盘8的设置使得本实施例的吸入给药组合结构更便于使用。In this embodiment, as shown in FIG. 16, the index plate 8 is provided with counting marks corresponding to more than two powder containing cavities. The marking plate 8 rotates synchronously with respect to the powder containing body to display the usage of the powder in the multiple powder containing cavities in the powder containing body. For example, for the medicine box of this embodiment, there are seven medicine powder containing chambers. When the medicine box of this embodiment is not in use, the count mark on the mark plate 8 is displayed as zero. With the gradual use of the medicine powder in the medicine powder accommodating cavity in the medicine box, the counting mark of the marking plate 8 gradually becomes larger. When the count mark on the marking plate 8 reaches seven, the patient can know that the powder in the medicine box has been used up, and can replace the medicine box with a new one. The setting of the indicator disc 8 makes the combined structure of inhalation and administration of this embodiment more convenient to use.

在其它实施例中,标志盘上的标志还可以包括药粉种类信息等药盒的使用信息。例如,当两个以上药粉容纳腔内容纳不同种类的药粉时,标志盘上的标志可以是与药粉容纳腔中的药粉种类相对应的药粉种类信息。In other embodiments, the mark on the mark disc may also include the use information of the medicine box such as the powder type information. For example, when two or more medicated powder containing chambers contain different types of medicated powder, the mark on the marking plate may be the powder type information corresponding to the type of medicated powder in the medicated powder containing chamber.

为了使标志盘8与药粉容纳体同步转动,如图16所示,标志盘8的内侧边缘上设置有标志盘棘齿。转盘13上设置有转盘棘爪131。转盘棘爪131与标志盘棘齿配合以驱动标志盘棘齿转动,同时转盘13带动棘爪盘9同步转动,因此使得标志盘8与药粉容纳体同步转动,从而标志盘8上的计数标志可示出药粉容纳体的药粉容纳腔的使用状态。In order to make the sign disc 8 rotate synchronously with the powder containing body, as shown in Fig. 16, a sign disc ratchet is provided on the inner edge of the sign disc 8. The turntable 13 is provided with a turntable pawl 131. The pawl 131 of the turntable cooperates with the ratchet teeth of the sign disc to drive the ratchet teeth of the sign disc to rotate. At the same time, the turntable 13 drives the pawl disc 9 to rotate synchronously, so that the sign disc 8 and the powder containing body rotate synchronously, so that the counting marks on the sign disc 8 can be It shows the state of use of the powder containing cavity of the powder containing body.

在一些实施例中,如图11所示,吸入给药组合结构还包括用于使转盘棘爪自动回位的弹性元件12,弹性元件12的第一端与转盘13相对固定地设置,弹性元件的第二端与盒体3相对固定地设置。In some embodiments, as shown in FIG. 11, the combined structure for inhalation administration further includes an elastic element 12 for automatically returning the pawl of the turntable. The first end of the elastic element 12 and the turntable 13 are relatively fixedly arranged. The second end of the box 3 is relatively fixedly arranged.

如图10所示,转盘13的底部设置有第一连接槽13A,弹性元件12的第一端连接于第一连接槽13A中。本实施例的吸入给药组合结构还包括相对于盒体3固定设置的限位盘11。限位盘11上设置有第二连接槽11B。弹性元件12的第二端连接于第二连接槽11B中。由于弹性元件12的第一端与转盘13固定连接,弹性元件12的第二端 与限位盘11固定连接,因此当转盘13在转动后能够在弹性元件12的拉动下自动回位。As shown in FIG. 10, the bottom of the turntable 13 is provided with a first connecting groove 13A, and the first end of the elastic element 12 is connected in the first connecting groove 13A. The combined structure of inhalation drug delivery in this embodiment further includes a limiting disk 11 fixedly arranged relative to the box body 3. A second connecting groove 11B is provided on the limit disk 11. The second end of the elastic element 12 is connected to the second connecting groove 11B. Since the first end of the elastic element 12 is fixedly connected to the turntable 13 and the second end of the elastic element 12 is fixedly connected to the limit disk 11, the turntable 13 can automatically return under the pulling of the elastic element 12 after rotating.

具体在本实施例中,弹性元件12为扭簧。Specifically, in this embodiment, the elastic element 12 is a torsion spring.

在一些实施例中,为了控制转盘棘爪131的转动范围以使多个药粉容纳腔依次与盒体3上的风粉出口连通进而实现患者对多个药粉容纳腔中的药粉的依次用药,如图14所示,本实施例的限位盘11上设置有限位槽11A。如图10所示,转盘13上设有限位凸起132。限位凸起132在限位槽11A内摆动以限制转盘棘爪131每次的转动范围。In some embodiments, in order to control the rotation range of the turntable pawl 131 so that the multiple powder accommodating cavities are sequentially connected with the air powder outlet on the box body 3 to realize the patient's sequential administration of the powder in the multiple powder accommodating cavities, such as As shown in FIG. 14, the limit disk 11 of this embodiment is provided with a limit slot 11A. As shown in FIG. 10, a limiting protrusion 132 is provided on the turntable 13. The limiting protrusion 132 swings in the limiting slot 11A to limit the rotation range of the turntable pawl 131 each time.

为了保证转盘棘爪131的限位的可靠性,本实施例的限位盘设置有对称布置的两个限位槽。两个限位槽分别与转盘13上的两个限位凸起配合。In order to ensure the reliability of the position limit of the turntable pawl 131, the limit disk of this embodiment is provided with two limit grooves arranged symmetrically. The two limiting grooves respectively cooperate with the two limiting protrusions on the turntable 13.

本实施例的驱动机构通过设置转盘13以及与转盘13同步转动的棘爪盘9以使转盘13上的转盘棘爪驱动标志盘8转动的同时转盘13驱动药粉容纳体转动,从而实现标志盘8对药粉容纳体的药粉使用状态的显示。而且转盘13上设置有旋钮,方便患者操作。The driving mechanism of this embodiment is provided with a turntable 13 and a pawl plate 9 that rotates synchronously with the turntable 13 so that the turntable pawls on the turntable 13 drive the sign plate 8 to rotate while the turntable 13 drives the powder containing body to rotate, thereby realizing the sign plate 8 Display of the powder usage status of the powder container. Moreover, a knob is provided on the turntable 13 to facilitate the operation of the patient.

利用第一制剂和第二制剂分别对设置有第一旋流结构的药盒的药粉抽吸效果以及未设置有第一旋流结构的药盒的药粉抽吸效果进行试验,其试验结果如表1所示。第一制剂的药粉颗粒直径为10μm。第二制剂的药粉颗粒直径为2.8μm。如表1中的试验数据所示,对于两种不同药粉颗粒直径的试剂,在装药量相同的情况下,设置有第一旋流结构的药盒的药粉抽吸量大于未设置第一旋流结构的药盒的药粉抽吸量。综上可知,设置第一旋流结构可以增大被抽吸出药盒的药粉量。The first preparation and the second preparation were used to test the powder suction effect of the medicine box with the first swirl structure and the powder suction effect of the medicine box without the first swirl structure. The test results are shown in the table 1 shown. The powder particle diameter of the first preparation is 10 μm. The diameter of the powder particles of the second preparation is 2.8 μm. As shown in the test data in Table 1, for two reagents with different powder particle diameters, under the same loading quantity, the powder suction volume of the medicine box with the first swirl structure is greater than that without the first swirl structure. The powder suction volume of the medicine box with flow structure. In summary, it can be seen that the provision of the first swirl structure can increase the amount of powder that is sucked out of the medicine box.

表1:设置有第一旋流结构的药盒的试验结果Table 1: Test results of the medicine box with the first swirl structure

Figure PCTCN2019100241-appb-000001
Figure PCTCN2019100241-appb-000001

利用第三制剂和第四制剂分别对设置有第一旋流结构和第二旋流结构的药盒的药粉抽吸效果以及设置有第一旋流结构而未设置有第二旋流结构的药盒的药粉抽吸效果进行试验,其试验结果如表2所示。在表2中,GMD(Geometric Mean Diameter)代表药粉颗粒的几何平均直径,MMAD(Mass Median Aerodynamic Diameter)代表药粉颗粒的质量平均空气动力学直径。其中,第三制剂的药粉颗粒的几何平均直径为2.1μm。第四制剂的药粉颗粒的几何平均直径为2μm。The use of the third preparation and the fourth preparation to suck the powder of the medicine box provided with the first swirl structure and the second swirl structure, and the medicine provided with the first swirl structure but not the second swirl structure The powder suction effect of the box was tested, and the test results are shown in Table 2. In Table 2, GMD (Geometric Mean Diameter) represents the geometric mean diameter of powder particles, and MMAD (Mass Median Aerodynamic Diameter) represents the mass average aerodynamic diameter of powder particles. Among them, the geometric mean diameter of the powder particles of the third formulation is 2.1 μm. The geometric mean diameter of the powder particles of the fourth formulation is 2 μm.

如表2中的试验数据所示,设置第二旋流结构的药盒所抽吸出的药粉的质量平均空气动力学直径要小于未设置有第二旋流结构的药盒所抽吸出的药粉的质量平均空气动力学直径。而且设置第二旋流结构的药盒所抽吸出的药粉中的质量平均空气动力学直径小于3.4μm和小于5μm的药粉的比例均大于未设置有第二旋流结构的药盒所抽吸出的药粉中相应质量平均空气动力学直径所占的比例。综上可知,第二旋流结构的设置能够使药粉充分雾化,更利于患者的吸收。As shown in the test data in Table 2, the mass average aerodynamic diameter of the powder sucked by the medicine box with the second swirl structure is smaller than that of the medicine box without the second swirl structure. The mass average aerodynamic diameter of the powder. In addition, the proportion of powders with a mass average aerodynamic diameter of less than 3.4 μm and less than 5 μm in the powder sucked by the medicine box with the second swirl structure is larger than that of the medicine box without the second swirl structure. The proportion of the average aerodynamic diameter of the corresponding mass in the powder. To sum up, it can be seen that the arrangement of the second swirling structure can fully atomize the powder, which is more conducive to the absorption of patients.

表2:设置有第一旋流结构和第二旋流结构的药盒的试验结果Table 2: Test results of the kit provided with the first swirl structure and the second swirl structure

Figure PCTCN2019100241-appb-000002
Figure PCTCN2019100241-appb-000002

综上可知,本公开实施例的吸入给药装置至少具有以下优势:In summary, the inhalation drug delivery device of the embodiments of the present disclosure has at least the following advantages:

该药盒内设置第一旋流结构可提高药粉的抽吸量。设置第二旋流结构提高药粉的雾化效果,从而提高患者吸入肺部的药粉量。The first swirling structure is arranged in the medicine box to increase the suction volume of the medicine powder. The second swirl structure is provided to improve the atomization effect of the powder, thereby increasing the amount of powder inhaled by the patient.

最后应当说明的是:以上实施例仅用以说明本公开的技术方案而非对其限制;尽管参照较佳实施例对本公开进行了详细的说明,所属领域的普通技术人员应当理解:依然可以对本公开的具体实施方式进行修改或者对部分技术特征进行等同替换,其均应涵盖在本公开请求保护的技术方案范围当中。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present disclosure and not to limit it; although the present disclosure has been described in detail with reference to preferred embodiments, those of ordinary skill in the art should understand that: Modifications to the disclosed specific implementations or equivalent replacements of some technical features shall be included in the scope of the technical solutions claimed in the present disclosure.

Claims (18)

一种吸入给药装置,其中,所述吸入给药装置包括用于引入外部空气的通气口(1A)、用于放置药盒的药盒放置腔和用于抽吸药盒的药粉容纳腔内的药粉的风粉抽吸口(16A),所述吸入给药装置还包括设置于所述通气口(1A)与所述药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构(5)。An inhalation drug delivery device, wherein the inhalation drug delivery device comprises a vent (1A) for introducing external air, a medicine box placement cavity for placing a medicine box, and a medicine powder accommodating cavity for sucking the medicine box The air-powder suction port (16A) of the powder, the inhalation drug delivery device also includes a device that is arranged between the vent (1A) and the powder-containing cavity and is used to cause the airflow to generate a swirl before the powder is blown The first swirl structure (5). 根据权利要求1所述的吸入给药装置,其中,所述吸入给药装置还包括设置于所述通气口(1A)与所述第一旋流结构(5)之间的均流结构。The inhalation drug delivery device according to claim 1, wherein the inhalation drug delivery device further comprises a flow sharing structure provided between the vent (1A) and the first swirl structure (5). 根据权利要求1所述的吸入给药装置,其中,所述第一旋流结构(5)包括气流入口端、气流出口端和设置于所述气流入口端和所述气流出口端之间的旋流通道,所述旋流通道包括从流道中心至流道边缘依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。The inhalation drug delivery device according to claim 1, wherein the first swirling structure (5) comprises an airflow inlet end, an airflow outlet end, and a swirling structure arranged between the airflow inlet end and the airflow outlet end. The swirling channel includes two or more swirling parts arranged sequentially from the center of the flow channel to the edge of the flow channel, and each swirling part is used to generate a swirling flow of a part of the air flow input into it and output it. 根据权利要求3所述的吸入给药装置,其中,所述第一旋流结构还包括设置于从流道边缘数第一个旋流部外侧的外侧导流面,所述外侧导流面至少在所述气流出口端一侧为从所述旋流通道的上游至下游逐渐变大的扩张面。The inhalation drug delivery device according to claim 3, wherein the first swirl flow structure further comprises an outer flow guide surface arranged outside the first swirl flow portion from the edge of the flow channel, and the outer flow guide surface is at least On the side of the air flow outlet end is an expansion surface that gradually increases from upstream to downstream of the swirling channel. 根据权利要求4所述的吸入给药装置,其中,所述扩张面包括锥面结构。The inhalation drug delivery device according to claim 4, wherein the expansion surface comprises a tapered surface structure. 根据权利要求3所述的吸入给药装置,其中,相邻的所述旋流部之间设置用于隔离两个旋流部的气流的隔离结构(53)。The inhalation drug delivery device according to claim 3, wherein an isolation structure (53) for isolating the airflow of the two swirling parts is provided between the adjacent swirling parts. 根据权利要求6所述的吸入给药装置,其中,所述隔离结构(53)包括用于为其隔离的两个旋流部中靠近中心的旋流部的气流导流的第一中间导流面和/或用于为其隔离的两个旋流部中靠近边缘的旋流部的气流导流的第二中间导流面。The inhalation drug delivery device according to claim 6, wherein the isolation structure (53) comprises a first intermediate guide for guiding the airflow of the swirling part near the center of the two swirling parts that are isolated for it. Surface and/or a second intermediate guide surface used to guide the airflow of the swirling portion near the edge of the two isolated swirling portions. 根据权利要求7所述的吸入给药装置,其中,所述第一中间导流面至少在气流出口端一侧为截面积从所述旋流流道的上游至下游逐渐变大的扩张面;和/或,所述第 二中间导流面至少在气流出口端一侧为截面积从旋流流道的上游至下游逐渐变大的扩张面。The inhalation drug delivery device according to claim 7, wherein the first intermediate flow guiding surface is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirling flow channel at least on the side of the air outlet end; And/or, the second intermediate flow guiding surface is an expansion surface whose cross-sectional area gradually increases from upstream to downstream of the swirling flow channel at least on the side of the air outlet end. 根据权利要求1所述的吸入给药装置,其中,所述第一旋流结构(5)设置于所述药粉容纳腔的用于引入气流的开口处。The inhalation drug delivery device according to claim 1, wherein the first swirling structure (5) is arranged at the opening of the medicinal powder containing cavity for introducing airflow. 根据权利要求1至9中任一项所述的吸入给药装置,其中,所述吸入给药装置还包括设置于所述药粉容纳腔与所述风粉抽吸口(16A)之间且用于使风粉混合物产生旋流的第二旋流结构(19)。The inhalation drug delivery device according to any one of claims 1 to 9, wherein the inhalation drug delivery device further comprises a device provided between the powder containing cavity and the powder suction port (16A) and used A second swirl structure (19) for generating a swirling flow of the wind and powder mixture. 根据权利要求10所述的吸入给药装置,其中,所述吸入给药装置还包括设置于所述第一旋流结构和所述第二旋流结构之间的风粉加速通道;和/或,所述吸入给药装置还包括设置于所述第二旋流结构(19)和所述风粉抽吸口(16A)之间的整流结构(151)。The inhalation drug delivery device according to claim 10, wherein the inhalation drug delivery device further comprises a wind and powder accelerating channel provided between the first swirling structure and the second swirling structure; and/or The inhalation drug delivery device further includes a rectifying structure (151) arranged between the second swirling structure (19) and the air powder suction port (16A). 根据权利要求10所述的吸入给药装置,其中,所述第二旋流结构(19)包括旋流通道和设置于所述旋流通道内的旋流叶片。The inhalation drug delivery device according to claim 10, wherein the second swirling structure (19) comprises a swirling channel and swirling blades arranged in the swirling channel. 根据权利要求12所述的吸入给药装置,其中,所述旋流叶片相对于所述旋流通道固定设置。The inhalation drug delivery device according to claim 12, wherein the swirling blade is fixedly arranged relative to the swirling passage. 一种吸入给药组合结构,包括药盒和用于抽吸放置于所述药盒内的药粉的吸入给药装置,其中,所述药盒具有用于放置药粉的药粉容纳腔,所述吸入给药装置包括用于引入外部空气的通气口(1A)、用于放置所述药盒的药盒放置腔和用于抽吸所述药粉容纳腔内的药粉的风粉抽吸口(16A),所述吸入给药装置还包括设置于所述通气口(1A)与所述药粉容纳腔之间且用于使气流在吹送药粉之前产生旋流的第一旋流结构(5)。An inhalation drug delivery combination structure, comprising a medicine box and an inhalation drug delivery device for sucking powder placed in the medicine box, wherein the medicine box has a powder containing cavity for placing the powder, and the inhalation The drug delivery device includes a vent (1A) for introducing external air, a medicine box placement cavity for placing the medicine box, and a powder suction port (16A) for sucking the medicine powder in the medicine powder accommodating cavity The inhalation drug delivery device further includes a first swirling structure (5) arranged between the vent (1A) and the powder accommodating cavity and used for causing the airflow to swirl before the powder is blown. 根据权利要求14所述的吸入给药组合结构,其中,所述药盒具有用于引入外部空气的进气口(3A),所述第一旋流结构(5)设置于所述进气口(3A)处。The inhalation drug delivery combination structure according to claim 14, wherein the medicine box has an air inlet (3A) for introducing external air, and the first swirling structure (5) is provided at the air inlet (3A) place. 根据权利要求14所述的吸入给药组合结构,其中,所述第一旋流结构包括气流入口端、气流出口端和设置于所述气流入口端和所述气流出口端之间的旋流通道,所述旋流通道包括从流道中心至边缘依次环绕布置的两个以上旋流部,每个旋流部用于将输入其中的部分气流产生旋流后输出。The combination structure for inhalation and drug delivery according to claim 14, wherein the first swirling structure comprises an airflow inlet end, an airflow outlet end, and a swirling flow channel arranged between the airflow inlet end and the airflow outlet end The swirling channel includes two or more swirling parts arranged sequentially from the center to the edge of the flow channel, and each swirling part is used to generate a swirling flow of a part of the airflow input into it and output it. 根据权利要求14所述的吸入给药组合结构,其中,所述吸入给药装置还包括设置于所述药粉容纳腔与所述风粉抽吸口(16A)之间且用于使风粉混合物产生旋流的第二旋流结构(19)。The inhalation drug delivery combination structure according to claim 14, wherein the inhalation drug delivery device further comprises a powder containing cavity and the air powder suction port (16A) and used to make the air powder mixture A second swirl structure (19) that generates swirl. 根据权利要求17所述的吸入给药组合结构,其中,所述第二旋流结构包括旋流通道和设置于所述旋流通道内的旋流叶片。The inhalation drug delivery combination structure according to claim 17, wherein the second swirling flow structure comprises a swirling flow channel and a swirling vane arranged in the swirling flow channel.
PCT/CN2019/100241 2019-08-12 2019-08-12 Inhalation administration device and combined inhalation administration structure Ceased WO2021026733A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/100241 WO2021026733A1 (en) 2019-08-12 2019-08-12 Inhalation administration device and combined inhalation administration structure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/100241 WO2021026733A1 (en) 2019-08-12 2019-08-12 Inhalation administration device and combined inhalation administration structure

Publications (1)

Publication Number Publication Date
WO2021026733A1 true WO2021026733A1 (en) 2021-02-18

Family

ID=74569341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/100241 Ceased WO2021026733A1 (en) 2019-08-12 2019-08-12 Inhalation administration device and combined inhalation administration structure

Country Status (1)

Country Link
WO (1) WO2021026733A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048953B2 (en) * 2000-04-03 2006-05-23 Inhalation, Inc. Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
CN101437562A (en) * 2006-03-03 2009-05-20 Stc.Unm公司 Dry powder inhaler with aeroelastic dispersion mechanism
CN101642735A (en) * 2009-03-18 2010-02-10 陈久斌 Atomizer
CN102688224A (en) * 2003-04-14 2012-09-26 维克特拉有限公司 Device and pharmaceutical composition enhancing administration efficiency
CN107432967A (en) * 2016-05-26 2017-12-05 兰州大学第医院 A kind of novel and multifunctional nebulization equipment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048953B2 (en) * 2000-04-03 2006-05-23 Inhalation, Inc. Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
CN102688224A (en) * 2003-04-14 2012-09-26 维克特拉有限公司 Device and pharmaceutical composition enhancing administration efficiency
CN101437562A (en) * 2006-03-03 2009-05-20 Stc.Unm公司 Dry powder inhaler with aeroelastic dispersion mechanism
CN101642735A (en) * 2009-03-18 2010-02-10 陈久斌 Atomizer
CN107432967A (en) * 2016-05-26 2017-12-05 兰州大学第医院 A kind of novel and multifunctional nebulization equipment

Similar Documents

Publication Publication Date Title
JP4335666B2 (en) Powder inhaler
EP0640354B1 (en) Whirl chamber powder inhaler
FI107126B (en) Powder inhaler for combination medicine
JP5297719B2 (en) Deagglomeration device
CN1859938B (en) Unit dose cartridges and dry powder inhalers
US20120247460A1 (en) Metered dose inhaler spacer
HU220450B1 (en) Dry powder inhaler
BG99579A (en) Inhalator for dry powder
BR0017519B1 (en) medicament capsule for an inhaler, and process for manufacturing a capsule comprising a powdered medicament.
PT1294421E (en) Dry powder inhaler
JP2011507594A (en) Dosage device and method for mixing powder in airflow 537
JPH08103499A (en) Inhaler
CN214232338U (en) A multi-dose reservoir type dry powder inhalation device
US20160367770A1 (en) Oral inhaler mixer system and method
JP2008500851A (en) Unit dose dry powder inhaler
AU2022358453C1 (en) Dry powder medicament inhaler
US6237591B1 (en) Turbine dry powder inhaler
WO2021026733A1 (en) Inhalation administration device and combined inhalation administration structure
CN110201279B (en) Medicine box for inhalation administration and inhalation administration combined structure
PL234586B1 (en) Inhaler of a single dose of dry powder
JP2016523823A (en) Inhalable pharmaceutical composition and inhaler device comprising the same
CN110201278B (en) Medicine box for inhalation administration and inhalation administration combined structure
CN110201280B (en) Suction nozzle for an inhalation device and inhalation device
CN110201281B (en) Inhalation administration device and inhalation administration combination structure
CN117771490B (en) A double-reservoir powder aerosol device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19941179

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19941179

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 19941179

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07/10/2022)

122 Ep: pct application non-entry in european phase

Ref document number: 19941179

Country of ref document: EP

Kind code of ref document: A1